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ABSTRACT 
 
 
Embryos from the annual killifish Austrofundulus limnaeus have a 
unique and unequalled ability among vertebrates to withstand extended 
periods of anoxia (maximum lethal time to 50% mortality of 65 days at 25°C).  
In addition, tolerance of anoxia is gained and subsequently lost during the 
normal development of this species. Thus, anoxia tolerant and anoxia 
sensitive individuals can be compared within the same species, making A. 
limnaeus an excellent model for studying the molecular changes associated 
with survival of oxygen deprivation in vertebrates.  The aim of this project is to 
analyze the molecular changes associated with anoxia tolerance in the 
embryos of A. limnaeus.  Understanding how the cells of these embryos 
become tolerant to anoxia will aid in identifying novel therapeutic targets to 
reduce cell death following periods of ischemia in heart, brain or other tissues.   
Three major analyses were used to investigate the molecular changes 
associated with anoxia tolerance in this species.  The first was a cell cycle and 
cell cycle arrest analysis using flow cytometry along with an immnuoblot 
analysis of both positive and negative regulators of cell cycle progression.  
The second was a cell death analysis utilizing caspase-3/7 activity as well as 
TUNEL staining.  The third was an immunoblot analysis of three different post-
translational modifers (ubiquitin, SUMO-1 and SUMO-2/3).   
 ii 
The overall findings from this study indicate that the embryos of A. 
limnaeus do indeed experience some degree of cellular stress (i.e. increase in 
ubiquitinated proteins, increase in p53 expression, evidence of DNA damage 
from TUNEL staining and increases in caspase activity) in response to anoxic 
treatment, even in their most protective state of diapause II.  However, despite 
these observations, the whole organisms are still able to recover from anoxia 
and do not succumb to death.  The overall low levels of TUNEL-positive cells 
and caspase activity relative to the positive controls indicates that the damage 
accrued in response to anoxic treatment is minimal.  It appears that embryos 
are able to either “sacrifice” a certain portion of cells or they are able to repair 
the damage required for resumed development following anoxia.  
 iii 
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CHAPTER 1:   
Anoxia Tolerance 
 
Oxygen is vital to life 
Oxygen serves a pivotal role in organismal physiology. Consequently, 
most eukaryotes are sensitive to periods of oxygen deprivation or conditions of 
reduced oxygen concentrations.  For animals, metabolically active tissues like 
the heart and brain are particularly sensitive to reduced oxygen.   
Cardiovascular diseases in humans such as heart attack and stroke often lead 
to severe tissue and organ damage, have high morbidity rates and are the 
leading cause of disability in the United States (Lloyd-Jones et al., 2010).  
Stroke is the most frequent cause of disability and as such produces a huge 
economic burden.  The major damages caused by heart attack and stroke are 
often due to the blockage of blood flow (ischemia) to tissues in the heart and 
brain.  Although much has been learned about the molecular mechanisms that 
mediate cell death following a period of ischemia, to date there are no 
therapeutic strategies to block these mechanisms.  As a result, a great deal of 
research effort has been dedicated to understanding endogenous 
mechanisms of protection. 
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Anoxia Tolerance in other species 
Many organisms have evolved altered cellular biochemistry and 
physiology that allows for prolonged survival of anoxia.  These endogenous 
mechanisms of protection are present in both vertebrate and invertebrate 
species.  This phenomenon is most dramatically demonstrated by the brine 
shrimp, Artemia franciscana.  The embryos of this species have been reported 
to survive up to four years of continuous anoxia (Clegg, 1997).  A small 
number of vertebrate species also exhibit extraordinary anoxia tolerance.  
Most vertebrates’ brains are unable to withstand more than a few minutes of 
anoxia, however some freshwater turtles (Trachemys scripta and Chrysemys 
picta), frogs (Rana pipiens and Rana temporaria), and fish (Crucian carp, 
goldfish, annual killifish) can survive anoxia for hours and some for months 
(Lutz and Nilsson, 2004; Podrabsky et al., 2007). 
Among fish species, the Crucian carp (Carassius carassius L.) and the 
goldfish (Carassius auratus L.) exemplify noteworthy anoxia tolerance.  Both 
can survive without oxygen for days at room temperature and the Crucian carp 
can survive months of anoxia at temperatures close to 0°C (Blazka, 1958; 
Holopainen and Hyvarinen, 1985; Piironen and Holopainen, 1986).  The 
embryos of some species of fish have also demonstrated anoxia tolerance.  
Zebrafish embryos can survive 24 hours in the absence of oxygen in a state of 
suspended animation where all observable movement, cell division, 
developmental progression and motility ceased (Padilla and Roth, 2001).  Wild 
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zebrafish embryos may not be routinely exposed to anoxic conditions and as 
such are not necessarily adapted for hypoxic or anoxic conditions.  On the 
other hand, annual killifish are routinely exposed to such conditions and 
therefore provide a useful model species to study the molecular and 
physiological underpinnings of anoxia tolerance.  
 
Overview of Annual Killifish 
The annual killifish, Austrofundulus limnaeus is a cyprinodont fish that is 
endemic to ephemeral ponds in regions of northern South America where it is 
most commonly found in the Maracaibo basin of Venezuela (Lilyestrom and 
Taborn, 1982; Taborn and Thomerson, 1978), a region that has been 
described as having extreme fluctuations in temperature and drought 
conditions (Podrabsky et al., 1998).  The adult and juvenile forms die out on a 
seasonal basis when their ponds desiccate during dry seasons (Nico and 
Thomerson, 1989).  This severe and unpredictable climate has given rise to 
several unique developmental adaptations, including the ability to enter a 
profound state of metabolic dormancy termed diapause, which allows 
populations of A. limnaeus to persist under conditions that are lethal to almost 
all other species of fish (Myers, 1952; Wourms, 1972a, c).  During this period 
of developmental arrest, the embryos are extremely resistant to a variety of 
harsh environmental conditions including a wide range of salt concentrations 
(Machado and Podrabsky, 2007), complete lack of oxygen (Fergusson-Kolmes 
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and Podrabsky, 2007; Podrabsky et al., 2007), extreme levels of oxidative 
stress (Knapp and Podrabsky, unpublished) UV-C radiation (Wagner, Vege 
and Podrabsky, unpublished), and complete dehydration of their habitat 
(Podrabsky et al., 2001).  Rainy periods cause the ponds to refill and the 
embryos resume development, hatch and continue the life cycle (Podrabsky 
and Hand, 1999). 
Embryos from the species Austrofundulus limnaeus have a unique and 
unequalled ability among vertebrates to withstand extended periods of anoxia 
(maximum lethal time to 50% mortality of 65 days at 25°C (Podrabsky and 
Somero, 2007).  In addition, tolerance of anoxia is gained and subsequently 
lost during the normal development of this species (Podrabsky et al., 2007). 
Thus, anoxia tolerant and anoxia sensitive individuals can be compared within 
the same species, making A. limnaeus an excellent model for studying the 
molecular changes associated with survival of oxygen deprivation in 
vertebrates.  The aim of this project is to analyze the molecular changes 
associated with anoxia tolerance in the embryos of A. limnaeus.  
Understanding how the cells of these embryos become tolerant to anoxia will 
aid in identifying novel therapeutic targets to reduce cell death following 
periods of ischemia in heart, brain or other tissues.   
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Organization of remaining chapters 
The three chapters that follow are organized into three distinct but 
related portions of this study that addresses the overarching goal of better 
understanding the proximal causes of anoxia tolerance exhibited by the cells 
of A. limnaeus embryos.  These chapters have been written as three 
independent publishable units.  The first of these chapters (Chapter 2) entitled, 
Cell cycle and cell cycle arrest, describes two sets of experiments.  The first 
experiment uses the technique of flow cytometry to estimate the proportion of 
cells in the various stages of the cell cycle at multiple time points across 
embryonic development.  The second is a series of immunoblot assays 
investigating the roles of an established positive and negative regulator on cell 
cycle progression (Cyclin D1 and p53, respectively) at three distinct embryonic 
developmental time points. 
The next chapter (Chapter 3) entitled, Cell death analysis, describes 
two sets of experiments designed to measure established markers of cell 
death or enzymatic activity that typically lead to cell death.  These assays 
were used to help determine whether the embryonic cells of A. limnaeus were 
avoiding the cell death that accompanies most organismal responses to 
anoxia.  The first experiment utilizes a fluorescent TUNEL assay (Terminal 
deoxynucleotide transferase dUTP Nick End Labeling) designed to measure 
DNA damage often indicative of cell death.  The second experiment uses a 
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luminescence-based assay to measure caspase-3/7 activity in four distinct 
embryonic stages. 
The next chapter (Chapter 4) entitled, Ubiquitination and SUMOylation 
analysis, describes two sets of immunoblot assays designed to measure 
protein modification by two well-known post-translational modifiers, ubiquitin 
and SUMO.  Both have been shown to be involved in ischemic protection and 
were therefore investigated in this study. 
The next chapter to follow (Chapter 5) entitled, Summary and future 
directions, describes my overall interpretation of results from the three major 
portions of the study, future directions for research, and the significance of this 
study to the overall topic of anoxia tolerance in vertebrate cells. 
The final chapter (Chapter 6) entitled, Establishing an embryonic cell 
line from Austrofundulus limnaeus, is not related to the overall anoxia 
tolerance study.  It is also not a hypothesis-driven experiment but rather a 
description of my efforts to establish an embryonic stem cell line from A. 
limnaeus embryos.  This chapter is provided to document the primary cultures 
that were unsuccessfully as well as successfully established and the 
preliminary data collected in order to better inform any future effort to culture 
embryonic stem cells in this species. 
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CHAPTER 2: 
Cell cycle and cell cycle arrest 
 
Background/Introduction 
Cells undergo a cycle of growth and division, which involves regulated 
and biochemically defined steps.  Intracellular as well as extracellular signals 
are used to determine whether a cell will enter and progress through a mitotic 
cycle or enter an alternative non-proliferative state such as quiescence or 
differentiation (Pardee, 1989).  The process is highly conserved and while 
some features such as the actual time required for the individual processes 
vary greatly between and amongst species, the basic molecular machinery 
remains virtually identical for all eukaryotes, from yeast to humans (Alberts et 
al., 2008). 
The eukaryotic cell cycle is divided into four major phases: G1, S, G2 
and M.  Within those four phases, the two major periods of transition are S-
phase denoting Synthesis and M-phase denoting Mitosis.  DNA replication 
occurs during S-phase, followed by chromosome segregation and nuclear 
division in the M-phase (Alberts et al., 2008).  Often cellular replication also 
includes time for the cell’s store of proteins and organelles to double in mass 
in order to supply two new daughter cells with all of the necessary molecular 
machinery.  Parenthetically, it can be noted that this is not true during early 
embryonic development as cell size is continuously reduced.  The two G-
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phases (G1 and G2), or gap phases (sometimes also referred to as “growth” 
phases) are in place to provide time for growth of these components.  
Together, the G1, S and G2 phases comprise a period of the cell cycle termed 
Interphase.  Cell cycle duration in zebrafish embryonic cells has been 
measured to range from 14.2 to 33.5 minutes depending on the 
developmental stage, with the earliest stages taking the least amount of time 
to complete a cycle (Kane and Kimmel, 1993). 
The gap phases of the cell cycle provide more than a pause for the cell 
to manufacture the components necessary for division.  They also provide 
checkpoints for determining whether conditions internally and externally are 
suitable for continuing the energetically costly and environmentally vulnerable 
process of cellular replication.  G1 is particularly important in determining 
whether the external environment is favorable.  If conditions are not suitable, 
cells can enter a specialized non-proliferating resting state known as G0 or 
quiescence, where they can remain for days, weeks, years or even 
permanently until death of the cell or death of the organism occurs (Pardee, 
1989).  Late in G1, there is a restriction point, where the commitment to enter 
or withdraw from a mitotic cycle occurs (Pardee, 1989).  The G1 checkpoint 
serves as an important point for determining if cells will arrest progression 
through the cell cycle.   
Passage through the restriction point and into S-phase requires the 
phosphorylation of the retinoblastoma tumor suppressor protein (Rb) which is 
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controlled by the actions of the Cyclin-dependent kinases (CDKs) (Vermeulen 
et al., 2003).  CDKs are central initiators of the cell cycle.  CDKs have positive 
regulatory subunits, the cyclins, and negative regulatory subunits, CDK-
inhibitory proteins (CKIs) (Vermeulen et al., 2003).  The D-type cyclins (D1, 
D2, and D3) are part of a group of G1 phase-specific cyclins whose activation 
is required for entry into S-phase (Koff et al., 1992; Lew et al., 1991; Xiong et 
al., 1991).  Cyclin-D dependent kinase activity is detected in mid-G1 phase as 
cells approach the G1/S boundary (Vermeulen et al., 2003).  Retinoblastoma 
protein is a negative regulator of the transcription factors that regulate G1 to S-
phase transition.  If conditions are favorable for cell proliferation, the CDKs will 
inactivate Rb by phosphorylation, releasing the transcription factors it once 
bound and allowing them to initiate transcription of the genes necessary for 
progression to S-phase (Vermeulen et al., 2003). 
The tumor suppressor protein, p53 is involved in multiple cellular stress 
response pathways and is central to cell survival.  Hypoxia has been shown to 
stimulate an increase in levels of p53 protein (Graeber et al., 1996).  p53 plays 
a pivotal role in the regulation of both apoptosis and cell cycle arrest and will 
therefore be a vital component of this study. In undamaged cells p53 is 
typically found in very low concentration and is highly unstable (Levine, 1997).  
It is bound to a protein called Mdm2, which acts as an ubiquitin ligase 
targeting p53 for proteasomal degradation.  When a cell experiences DNA 
damage, various protein kinases are recruited to the sites of DNA damage 
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initiating a signaling pathway that can halt progression through the cell cycle.  
The first kinases on site are either ATM or ATR, which in turn recruit and 
activate check point kinase 1 (Chk1) and Chk2.  Chk1 and Chk2 act to 
phosphorylate the transcription factor p53.  When p53 is phosphorylated it 
causes Mdm2 to be released.  Unbound p53 is no longer targeted for 
proteasomal degradation and its concentration increases.  In higher 
concentration, p53 stimulates gene transcription of the CKI protein, p21.  The 
p21 protein in turn, binds and inactivates the G1/S-Cdk and S-Cdk complexes, 
arresting the cell in G1. 
The aim of this chapter was to determine the phase of cell cycle arrest 
for A. limnaeus embryos during entry into metabolic dormancy associated with 
diapause and anoxia-induced quiescence.  The rationale for this approach 
arose from previous studies that showed cells from zebrafish embryos 
arrested in S and G2/M phase following anoxia treatment (Padilla and Roth, 
2001).  Zebrafish, however, do not exhibit long-term tolerance of anoxia, thus 
the significance of this type of cell cycle arrest is unclear.  Alternatively, A. 
limnaeus embryos are tolerant of long-term anoxia (Podrabsky et al., 2007).  
Determining the point in the cell cycle at which cells arrest during dormancy is 
a first step towards understanding the molecular mechanisms that control the 
cell cycle during dormancy and will aid in determining what intracellular 
conditions are necessary for supporting metabolic dormancy associated with 
diapause and anoxia-induced quiescence. 
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Hypotheses 
 As naturally anoxia tolerant organisms, A. limnaeus embryos may 
possess a mechanism for arresting progress in the cell cycle prior to 
replication of their DNA.  I therefore hypothesized that the anoxia-tolerant cells 
from A. limnaeus embryos would arrest in the G1 phase of the cell cycle, and 
that the molecular events associated with this arrest would result in an anoxia 
tolerant phenotype.  Flow cytometry was used to determine the phase of cell 
cycle arrest for normoxic and anoxia-treated A. limnaeus embryos throughout 
embryonic development.  Western blot analysis was also used to investigate 
the possible role of cyclin D1 and p53 in regulating cell cycle arrest associated 
with diapause and anoxia-induced quiescence.   I hypothesized that for the 
anoxia tolerant embryos, cyclin D1, a positive cell cycle regulator, would 
decrease in response to anoxia and p53, a negative cell cycle regulator, would 
in increase in response to anoxic treatment. 
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Materials and Methods 
 
Exposure to Anoxia 
The protocol used for the anoxia treatment for this study was previously 
described by Podrabsky et al. (Podrabsky et al., 2007).  Briefly, embryos were 
washed and transferred to a glass vial with nitrogen-purged embryo medium 
(45-60 min of robust bubbling).  To ensure anoxic conditions, sodium sulfite 
was added to a final concentration of 1 mg/ml to scavenge residual oxygen.  
This amount of sodium sulfite has been previously illustrated to have no toxic 
effect on the embryos (Podrabsky et al., 2007).  The vials were sealed, placed 
in a plastic bell jar gassed with N2 for 5 minutes, and then stored under 
vacuum at room temperature (~24-26°C).  
 
Cell Cycle Analysis by Flow Cytometry  
Cells were harvested from whole embryos at the following 
developmental stages:  3, 7, 10, 14, 17, 20, 24 days post-fertilization (dpf); 
Diapause II, and 4, 12, 24 and 36 days post diapause (dpd).  Two 
independent sample sets of the pre-diapause II developmental time points 
were prepared and three independent sample sets of diapause II and post-
diapause II developmental time points were prepared from matched sets of 
embryos developing under normoxic conditions as well as embryos that had 
been exposed to 24 hours of anoxia. 
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To prepare embryonic cells for the cell cycle analysis, 200 to 300 
embryos (normoxic controls and those exposed to anoxia for 24 hours) were 
dissociated into single-cell suspensions using a small 24mm, 500µm-mesh 
basket (Netwell™, Corning Product #3480) in a 50mm Petri dish and a glass 
pestle.  Cell suspensions were then rinsed several times in serum-free L-15 
(Cellgro® Leibovitz’s L-15 Medium with L-glutamine #10-045-CV) media to 
remove yolk proteins.  The cells were pelleted by centrifugation (300 x g, 5 
min) and resuspended in 200µl of phosphate buffered saline (PBS).  Cells 
were permeabilized and fixed with the addition of 1 ml methanol (100%) and 
then incubated with propidium iodide (PI) (1 mg/ml) for 10 min at room 
temperature.  Cells were then washed with PBS and stored at 4°C until the 
day of the assay (cells were processed within 24 hr of preparation).  
Cells were analyzed by flow cytometry (Cytopeia Influx Analyzer, 
Cytopeia Incorporated ©2004) at the Oregon Stem Cell Center, Flow 
Cytometry Core at Oregon Health Sciences University.   
 
Immunoblot Analysis of Cyclin D1 and p53 Proteins:  
To complement the flow cytometry cell cycle analysis, western blot 
analysis of levels of cyclin D1 (a marker for G1 of the cell cycle) and p53 (an 
important G1 checkpoint regulator) was performed. 
Cells were harvested from whole embryos at the following 
developmental stages:  diapause II, 4 days post-diapause II (dpd), and 12 
 14 
dpd.  For the Diapause II and 4 dpd developmental time-points, embryos were 
sampled after a harmful anoxic exposure [DII – 21 days, 4 dpd – 32 days, 12 
dpd – 72 hours; 50% of the LT50 value; (Podrabsky et al., 2007)] and after 24 
hr of subsequent normoxic recovery from the anoxic exposure.  Embryos at 12 
dpd were treated with an additional “preconditioning” regime that has been 
previously shown to induce increased survival of anoxia in this stage of 
embryo (Riggs and Podrabsky, unpublished).  The sampling regime for all 
three stages used for the immunoblots is presented in Figure 2.1.  Three 
independent sample sets were prepared for each of the three developmental 
time points (diapause II, 4 dpd and 12 dpd).  A matched normoxic control 
sample was prepared for each set of anoxic samples.   
To prepare samples for immunoblot analysis, 50 to 100 embryos were 
transferred to a small 24mm, 500 µm-mesh basket (Netwell™, Corning 
Product #3480) in a 50mm Petri dish containing 2ml of PBS and protease 
inhibitor (Roche Complete Mini, #11836153001).  Embryos were dissociated 
into cell suspensions by using a flat-bottom glass pestle to mash the embryos 
through the screen.  Cell suspensions were then transferred to a 1.7ml 
microcentrifuge tube and pelleted (300 x g, 5 min).  The cells were then rinsed 
two times in PBS with protease inhibitor to remove yolk proteins.  After the 
final rinse all the supernatant was removed and the cell pellet was snap-frozen 
in liquid nitrogen.  Samples were stored at -80°C until the day of analysis. 
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Embryo lysates were prepared for immunoblot by lysing the cells in a 
buffer (0.1M NaCl, 0.02M Tris-HCl, pH 7.6, 1mM EDTA, pH 8.0, 1% NP-40) 
containing protease inhibitors (0.99 µg/ml aprotinin, 0.3 µg/ml leupeptin, 1.5 
µg/ml pepstatin and 15 µg/ml PMSF and a phosphatase inhibitor cocktail (15 
µg/ml, Sigma P2850) used as prescribed by the manufacturer.  Lysates were 
sonicated at 15% amplitude for 10 to 15 seconds or until homogenized 
(Branson Digital Sonifier, S-450D).  Total protein was determined using a 
Bradford Protein Assay according to the manufacturer’s instructions (Bio-Rad 
#500-0205).  A standard curve containing 12.5, 6.25, 3.125, 1.75 and 0 µg of 
BSA was used to calculate the total protein concentration in each of the 
samples.  All samples were read on a Molecular Devices Spectramax plate 
reader.  Lanes were loaded with equal amounts of protein (25µg).  Samples 
were boiled for 5 min at 100°C prior to loading. 
Lysates were loaded on a 10% SDS-polyacrylamide gel and subjected 
to electrophoresis (115mV for ~2 hr).  Proteins were transferred onto PVDF 
membranes (30V, overnight).  The following day the membranes were blocked 
with 5% nonfat dried milk in Tris-buffered saline with 0.1% Tween (TBST 
solution) for 30 min on an agitator at room temperature.  After blocking, the 
membranes were incubated on a rotator with primary antibody in 5% nonfat 
dried milk/TBST solution in a sealed plastic bag for 2 hr at room temperature 
(cyclin D1 primary antibody diluted 1:1000, Manufacturer: Neomarkers #Rb-
010-PO, rabbit polyclonal; p53 primary antibody diluted 1:500, Manufacturer:  
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Santa Cruz #6243, rabbit polyclonal).  Membranes were removed from the 
plastic bag then washed for 5 – 10 min four times in TBST on an agitator at 
room temperature.  For secondary antibody incubation, membranes were 
again sealed in a plastic bag and incubated with HRP-conjugated secondary 
antibody in 5% nonfat dried milk/TBST solution (anti-rabbit secondary antibody 
used for both cyclin D1 and p53 conjugated membranes was diluted 1:2000, 
Cell Signaling #7074). 
Antigen binding was determined by chemiluminescence (Visualizer™ 
Western Blot Detection Kit – mouse, Millipore #64-201) and detected digitally 
using a digital image station (Kodak image station 2000RT) and analyzed with 
1D 3.6 software.  Protein levels (intensity) were determined digitally and 
expressed as OD units and normalized to a standard normoxic sample so that 
samples from different developmental stages and those run on different blots 
could all be compared on a common scale. 
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Figure 2.1. Sampling regimen for embryos exposed to anoxia and subsequent 
recovery from anoxia for western blot analysis. 
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Results 
 
Anoxic Preconditioning 
 The anoxic preconditioning experiment (Fig. 2.2) was carried out on 
embryos that were 12 dpd, a period of embryonic development in which the 
embryos are relatively sensitive to anoxia for this species.  While overall 
survival was not enhanced with both sets of embryos reaching 0% survival by 
around 18 days of anoxia, the embryos that received the anoxic 
preconditioning treatment had a significantly greater LT50 value (~10.2 days) 
than the control embryos (7.4 days) (two-way ANOVA, F(7,56)=122.57, 
p<0.0001). 
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Figure 2.2. Initial survival of 12 dpd embryos of A. limnaeus exposed to 
anoxia is significantly enhanced (two-way ANOVA, F(7,56)=122.57, p<0.0001) 
in preconditioned (LT50 = 10.2 ± 0.8 days) compared to control embryos (LT50 
= 7.4 ± 0.7 days).  Symbols represent means ± S.E.M. (n=5). 
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Flow Cytometry 
 The vast majority of cells isolated from embryos of A. limnaeus were in 
the G1 phase of the cell cycle regardless of developmental stage or treatment 
with anoxia (Figures 2.3 – 2.6).  Only during very early development, prior to 
the formation of the embryonic axis, were there a significant number of cells in 
S or G2 phases (Figures 2.3 and 2.4).  It appears that cells arrest in whatever 
stage of the cell cycle that they happen to be in when they are exposed to 
anoxia in stages that are older than 3 dpf.  For 3 dpf embryos, a high 
proportion of the embryos appeared to be in S phase, but these cells 
disappeared leaving 2 distinct populations of cells in G1 and G2 after exposure 
to 24 hr of anoxia (Figure 2.3).
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Figure 2.3. Flow cytometry cell cycle analysis of cells isolated from early 
embryos through diapause II (24 dpf) exposed to normoxia (green) or 24hr of 
anoxia (red).  Most cells are in G1 during the duration of early development 
through diapause II. 
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Figure 2.4. Percent of cells isolated from early embryos through diapause II in 
either G1 (white) or G2 (gray) phases of the cell cycle based on flow cytometry 
analysis.  Bars are means and error bars are the range (n=2). 
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Figure 2.5.  Flow cytometry analysis of post-diapause II embryos exposed to 
normoxia (N) or 24 hr of anoxia (A).  The age of the embryos is listed above 
the panels.  Three independent replicates (n=3) are presented for each stage 
(green, red, blue). 
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Figure 2.6. The percent of cells in post-diapause II embryos exposed to 
normoxia (N) or 24hr of anoxia (A) in G1 (white) or G2 (gray).  Bars represent 
means and error bars are S.E.M. (n=3).  Two-way ANOVA indicates no 
significant affect of anoxia on the proportion of cells in G1 (p=0.15), while there 
is a significant difference between developmental stages, F(4,10)=148.7, 
p<0.0001.  
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p53 
 The levels of p53 appeared to be very low in normoxic diapause II 
embryos (Figure 2.7).  Upon exposure to anoxia however, levels of p53 protein 
increased significantly (one-way ANOVA, F(2,6) =6.69, p=0.0296, Bonferroni 
post hoc, p<0.05).  After 24 hours of normoxic recovery the levels of p53 
decreased by ~50% but were still significantly higher than the normoxic control 
(one-way ANOVA, F(2,6)=6.69, p=0.0296, Bonferroni post hoc, p<0.05).  The 
pattern of p53 expression in the 4 and 12 dpd embryos appeared to be 
reversed from that of the diapause II embryos.  p53 appeared to be 
constitutively expressed in these embryos and decreased by ~50% upon 
harmful anoxic treatment although the decrease was not significant in either 
sample set (4 dpd: one-way ANOVA, F(2,6)=4.90, p>0.05, 12 dpd: one-way 
ANOVA, F(2,6)=1.03, p>0.05).  Similarly, p53 levels recovered to normoxic 
control levels following 24 hours of normoxic recovery.  
The anoxia sensitive, 12 dpd embryos, were further tested in an anoxic 
preconditioning regimen (see Figure 2.1).  For these embryos, there were no 
significant differences (one-way ANOVA, F(6,14)=1.75, p>0.05) in response to 
harmful anoxia or subsequent aerobic recovery in the preconditioned embryos 
as compared to the non-preconditioned embryos (Figure 2.8). 
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Cyclin D1 
 For normoxic embryonic cells in diapause II, the levels of cyclin D1 
were expressed at low levels (Fig. 2.9).  Upon 48 hours of anoxic exposure 
these levels rose slightly and remained slightly elevated after 24 hours of 
normoxic recovery.  However, none of these changes were statistically 
significant (one-way ANOVA, F(2,6)=5.03, p>0.05, Bonferroni post hoc 
p>0.05).  For embryonic cells isolated from 4 dpd embryos there was an 
increase in the level of cyclin D1, however this was only true for one sample 
and due to this variability the change was not statistically significant (one-way 
ANOVA, F(2,6)=0.49, p>0.05, Bonferroni post hoc p>0.05).  After 24 hours of 
normoxic recovery the levels of cyclin D1 were not significantly different in 
comparison to the normoxic control sample (one-way ANOVA, F(2,6)=0.49, 
p>0.05, Bonferroni post hoc p>0.05).  The 12 dpd samples exhibited the 
lowest overall levels of cyclin D1 out of the three developmental stages tested.  
There were no significant changes in cyclin D1 expression in response to 
anoxic treatment in this developmental stage (one-way ANOVA, F(2,6)=0.29, 
p>0.05, Bonferroni post hoc p>0.05). 
The 12 dpd, anoxia sensitive embryos were further tested in an anoxic 
preconditioning regimen (see Figure 2.1).  There were no significant changes 
in cyclin D1 expression (one-way ANOVA, F(6,14)=1.33, p>0.05, Bonferroni 
post hoc p>0.05) following harmful anoxic exposure in the preconditioned 
embryos as compared to the non-preconditioned embryos (Figure 2.10).
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Figure 2.7. Top panel: Immunoblot analysis of p53 expression in diapause II, 
4 dpd and 12 dpd embryos; Normoxic control (Con), 48hrs of anoxia (Anox) 
and 24 hours of normoxic recovery (Rec).  Bars represent means and error 
bars are S.E.M. (n=3). (DII: one-way ANOVA, F(2,6)=6.69, p=0.0296) (4 dpd: 
one-way ANOVA, F(2,6)=4.90 p>0.05) (12 dpd: one-way ANOVA, 
F(2,6)=1.03, p>0.05). Asterisks represent values that differ significantly from 
normoxic control values (Bonferroni post hoc, p<0.05). Data were log 
transformed prior to statistical analysis in order to meet assumptions of normal 
distributions for one-way ANOVA. 
Bottom panel: representative western blots from DII, 4 dpd and 12 dpd 
samples. Asterisk denotes the 53kDa p53 protein. 
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Figure 2.8. Top panel: 12 dpd embryos were preconditioned with a non-
harmful treatment of 48 hours of anoxia and then subsequently exposed to 
harmful anoxia (72 hrs).  Con=Normoxic control, A=harmful anoxia (72hrs 
anoxia), A/R=harmful anoxia (72hrs) followed by 24 hrs recovery, P=anoxia 
preconditioning treatment (48hrs), P/R=preconditioning (48hrs) followed by 
24hrs recovery, P/R/A=preconditioning (48hrs) followed by 24hrs recovery 
followed by harmful anoxia (72hrs), P/R/A/R=preconditioning (48hrs) followed 
by 24hrs recovery followed by harmful anoxia (72hrs) followed by 24hrs 
recovery.  Bars represent means and error bars are S.E.M. (n=3). One-way 
ANOVA analysis revealed no significant changes from normoxic control 
values, F(6,14)=1.75, p>0.05. Data were log transformed prior to statistical 
analysis in order to meet assumptions of normal distributions for one-way 
ANOVA. 
Bottom panel: representative western blots from the same 12 dpd samples. 
Asterisk denotes the 53kDa p53 protein. 
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Figure 2.9. Top panel: Immunoblot analysis of cyclin D1 expression in 
diapause II, 4 dpd and 12 dpd embryos; normoxic control (Con), 48hrs of 
anoxia (Anox) and 24 hours of normoxic recovery (Rec).  Bars represent 
means and error bars are S.E.M. (n=3). One-way ANOVA analysis revealed 
no significant changes from normoxic control values (DII: one-way ANOVA, 
F(2,6)=5.03, p>0.05) (4 dpd: one-way ANOVA, F(2,6)=0.49 p>0.05) (12 dpd: 
one-way ANOVA, F(2,6)=0.29, p>0.05). Data were log transformed prior to 
statistical analysis in order to meet assumptions of normal distributions for 
one-way ANOVA. 
Bottom panel: representative western blots from DII, 4 dpd and 12 dpd 
samples. Asterisk denotes the cyclin D1 protein. 
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Figure 2.10. Top panel: 12 dpd embryos were preconditioned with a non-
harmful treatment of 48 hours of anoxia and then subsequently exposed to 
harmful anoxia (72 hrs).  Con=normoxic control, A=harmful anoxia (72hrs 
anoxia), A/R=harmful anoxia (72hrs) followed by 24 hrs recovery, P=anoxia 
preconditioning treatment (48hrs), P/R=preconditioning (48hrs) followed by 
24hrs recovery, P/R/A=preconditioning (48hrs) followed by 24hrs recovery 
followed by harmful anoxia (72hrs), P/R/A/R=preconditioning (48hrs) followed 
by 24hrs recovery followed by harmful anoxia (72hrs) followed by 24hrs 
recovery.  Bars represent means and error bars are S.E.M. (n=3). One-way 
ANOVA analysis revealed no significant changes from normoxic control 
values, F(6,14)=1.33, p>0.05. Data were log transformed prior to statistical 
analysis in order to meet assumptions of normal distributions for one-way 
ANOVA. 
Bottom panel: Representative western blots from the same 12 dpd samples. 
Asterisk denotes the cyclin D1 protein. 
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Discussion  
The first aim of this chapter was to determine the stage of the cell cycle 
at which the embryonic cells of A. limnaeus arrest in response to anoxia.  It 
was hypothesized that the anoxia-tolerant cells from A. limnaeus embryos 
would arrest in the G1 phase of the cell cycle.  Early embryos of A. limnaeus 
initially begin with very little anoxia tolerance.  As the embryos develop and 
progress towards diapause II, they gradually acquire a greater degree of 
anoxia tolerance, reaching the peak of tolerance during diapause II and 
maintaining that peak tolerance at four days post-diapause II (Podrabsky et 
al., 2007).  Following this period of peak anoxia tolerance they become 
sensitive to anoxia again (Podrabsky et al., 2007).  Flow cytometry indicates 
that for embryos maintained in a normoxic environment, a majority of the cells 
are in G1 during the entire course of embryonic development.  The only time 
that cells in G2 increase in proportion is during very early development (3 dpf) 
and when the embryos are exiting diapause II at 4 days post-diapause II.  For 
embryos exposed to 24 hours of anoxia this pattern remains the same.  
Therefore, it appears that cells from A. limnaeus embryos arrest exactly where 
they are in the cell cycle at any given point during development.  Early 
embryos at 3 dpf are the one exception as they exhibit a number of cells in S 
phase under aerobic conditions, but not under anoxic conditions (Figure 2.2).  
These cells presumably either die immediately or progress to G2 within the first 
24 hr of anoxia.  Most of the cells at any given time are in G1, and thus they 
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enter into dormancy (either diapause or anoxia-induced quiescence) prior to 
entry into S phase. 
Arresting the cell cycle in G1 may be favorable during dormancy for 
several reasons.  First, the integrity of only a single copy of the genome must 
be maintained which may reduce the chances of damage occurring and/or 
reduce the cost of maintenance of the genome during dormancy or upon 
recovery from dormancy.  For organisms routinely exposed to unfavorable 
environmental conditions during development, this strategy could be 
considered highly adaptive.  A much smaller proportion of cells at any given 
time would be “stuck” with two copies of the genome to maintain during 
dormancy, a time when energy production is severely limited.  A large 
proportion of cells isolated from zebrafish embryos arrest in the S (77.7%) and 
G2/M (22.3%) phases upon exposure to anoxia (Padilla and Roth, 2001).  It is 
not clear how or why these cells die after exposure to anoxia, but it is possible 
that the difference in cell cycle arrest patterns observed in these two species 
may help to explain the differences in anoxia tolerance observed. 
 The second aim of this chapter was to determine whether certain cell 
cycle regulators (specifically cyclin D1 and p53) played a role in cell cycle 
arrest in response to anoxia treatment. The cyclins are positive regulators of 
cell cycle progression.  The D-type cyclins are a G1-specific group of cyclins 
necessary for progression to S-phase.  Immunoblot analysis of cyclin D1 
levels indicated higher levels of cyclin D1 during the 4 dpd stage as compared 
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to the diapause II and 12 dpd stages.  The overall level of cyclin D1 was much 
higher than those of diapause II and 12 dpd embryos.  This increase in cyclin 
D1 during the 4 dpd stage coincides with the slight increase in the number of 
G2 cells observed from the flow cytometry analysis also appearing during this 
stage.  These data suggest that cyclin D1 may be acting as a positive 
regulator on cell cycle progression as the embryos come out of diapause and 
resume development.   
 The transcription factor p53 is a negative regulator of cell cycle 
progression.  It was hypothesized that p53 levels would increase under anoxic 
conditions, thereby negatively regulating cell cycle progression. The basal 
levels of p53 during diapause II for embryos maintained in normoxic conditions 
were almost zero indicating that p53 does not impact cell cycle regulation to a 
large degree in normoxic diapause II embryos.  As hypothesized, p53 
expression increased significantly following harmful anoxic treatment.  Levels 
then dropped slightly after 24 hours of subsequent aerobic recovery but still 
remained significantly elevated relative to the normoxic control.  These data 
suggest that p53 is indeed involved in arresting the cell cycle in response to 
anoxia in this stage of embryo. 
 Interestingly this pattern was reversed in the 4 dpd and 12 dpd 
embryos.  Basal levels of p53 for normoxic embryos that have resumed 
development are higher in concentration than during diapause when 
development is arrested.  Although the changes were not statistically 
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significant, there was an interesting trend in both sets of embryos following 
exposure to anoxia.  p53 expression was initially high in the normoxic controls 
and decreased by ~50% in both sets of embryos following harmful anoxic 
treatment and similarly returned to approximately the normoxic values upon 24 
hours of aerobic recovery.  These data indicate that p53 is not acting as a 
negative regulator of cell cycle progression in response to harmful anoxia 
during the post-diapause II developmental stages.  The elevated basal 
(normoxic control) levels of p53 observed in the two post diapause stage 
sample sets may however be attributed to p53’s role in DNA repair (Sarasin 
and Dessen, 2010; Smith et al., 1995; Wang et al., 1995).  This alternate 
function of p53 may be an important mechanism for repairing damage that 
accumulated during diapause II. 
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CHAPTER 3: 
Cell Death Analysis 
 
Background/Introduction 
Cell death is a necessary and vital feature of normal development and 
organismal function.  If mitosis occurred without cell death, an 80-year-old 
human body would contain two tons of bone marrow and lymph nodes and a 
gut that could span 16 km (Melino, 2001).  Cell death is an inevitable process, 
and regulated cell death pathways have been highly conserved through 
evolutionary time.  The control of regulated cell death is highly complex and 
cells are continuously integrating signals from pro-survival and pro-death 
inputs.   
Traditionally, it has been thought that cells dying via regulated cell 
death pathways are engaged in a process that is reversible until they reach a 
“point-of-no-return” (Kroemer et al., 2009).  Several phenomena have been 
proposed to represent this critical turning point, including: massive caspase 
activation (Cohen, 1997), loss of mitochondrial inner membrane potential 
(Green and Kroemer, 1998), complete permeabilization of the outer 
mitochondrial membrane (Green and Kroemer, 2004), and exposure of 
phosphatidylserine residues on the outer leaflet of the plasma membrane 
(Fadok et al., 1992).  A review of the literature on this topic, however, indicates 
numerous examples where each of these scenarios fails to result in cell death.  
 36 
For example, caspases can be activated in cell differentiation pathways as 
well as many other non-lethal processes (Galluzzi et al., 2008; Garrido and 
Kroemer, 2004), protonophores can dissipate mitochondrial membrane 
potential without leading to cell death (de Graaf et al., 2004), and 
phosphotidylserine exposure can be reversible (Yang et al., 2002). In 
summary, the biochemical restriction point for cell death has yet to be 
universally defined. 
 
Defining Cell Death 
Historically, the different categories of cell death have been defined 
based on cell morphological characteristics, although numerous other 
classification schemes have been proposed as well. At least twelve different 
modalities of cell death have been categorized by the 2009 NCCD, including: 
apoptosis, necrosis, autophagy, cornification, mitotic catastrophe, anoikis, 
excitotoxicity, wallerian degeneration, paraptosis, pyroptosis, pyronecrosis, 
and entosis (Kroemer et al., 2009).  Cell death can be defined by functional 
aspects (programmed versus accidental or physiological versus pathological), 
by enzymatic involvement (dependent or independent of caspases, calpains, 
cathepsins, or transglutaminases), or by immunological characteristics 
(immunogenic or non-immunogenic) (Kroemer et al., 2009).  As the 
biochemical processes of cell death have become more defined, the 
definitions have taken on a more molecular/mechanistic nomenclature.   
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Regardless of the mechanism of cell death (regulated or unregulated), 
defining a cell as dead is not a straightforward task.  The Nomenclature 
Committee on Cell Death (NCCD) (Kroemer et al., 2009) recommends 
defining a cell as dead when it meets one of the three following molecular or 
morphological criteria:  [1] The cell has lost the integrity of its plasma 
membrane and is able to incorporate vital dyes (i.e. propidium iodide), [2] The 
cell has undergone complete fragmentation (including the nucleus) into 
discrete apoptotic bodies, or [3] the cell has been engulfed by an adjacent cell 
in vivo (Kroemer et al., 2009). 
 
Programmed Versus Uncontrolled Cell Death 
Although the terms apoptosis and programmed cell death are often 
used interchangeably, apoptosis is but one form of programmed cell death.  
Apoptosis is defined by a specific set of morphological features including: cell 
shrinkage (pyknosis), rounding up of the cell, retraction of pseudopodes, 
chromatin condensation, nuclear fragmentation (karyorrhexis), classically little 
to no modification of cytosolic organelles, and in the final stages, “blebbing” of 
the plasma membrane into apoptotic bodies, and often subsequent 
engulfment of these apoptotic bodies by resident phagocytes (Kroemer et al., 
2009).  Programmed cell death as opposed to uncontrolled cell death is 
implemented by a genetic program and requires some minimal level of ATP 
(Hand and Menze, 2008).   
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Necrosis is largely considered an unregulated cell death modality.  
Necrotic cell death is characterized morphologically by the absence of 
apoptotic or autophagic markers (Kroemer et al., 2009).  Necrotic cells are 
identified by: cytoplasmic swelling (oncosis), swelling of cytoplasmic 
organelles, moderate chromatin condensation, and eventually rupture of the 
plasma membrane (Kroemer et al., 2009).  The contents of necrotic cells 
released into the extracellular space can activate inflammation responses or 
damage other neighboring cells, thereby spreading the necrotic area (Hand 
and Menze, 2008).   
Although necrosis has historically been considered an accidental and 
unregulated form of cell death, recent evidence has shown that necrosis can 
be induced by some of the death domain receptors (i.e. TNFR1, Fas/CD95 
and TRAIL-R) and toll-like receptors (TLR3 and TLR4) especially in the 
absence of caspase induction (Festjens et al., 2006; Golstein and Kroemer, 
2007; Holler et al., 2000).  Regulated necrosis appears to be dependent on 
the activation of the kinase RIP1 (Festjens et al., 2006; Golstein and Kroemer, 
2007; Holler et al., 2000).  There is no consensus on the biochemical features 
that cause or define necrosis and for that reason it is still defined negatively in 
terms of apoptosis (Kroemer et al., 2009).  
There are other forms of programmed cell death that do not result in the 
manifestation of the apoptosis-specific morphologies (Kroemer et al., 2009).  
For instance, cornification is a particular form of programmed cell death that 
 39 
occurs in the epidermis leading to the formation of corneocytes or dead 
keratinocytes that function as the cornified skin layer (Candi et al., 2005; 
Lippens et al., 2005).  It is morphologically and biochemically distinct from 
apoptosis (Kroemer et al., 2009; Lippens et al., 2005).  Cornification is largely 
considered a terminal differentiation program similar to the processes that lead 
to anucleation in mature erythrocytes and in lens epithelium cells (Counis et 
al., 1998; Testa, 2004). However, unlike the anucleated erythryocytes and lens 
epithelial cells, cornified cells are able to undergo stress-induced death and 
display activation of the cell death machinery, mainly the caspases.  Thus, 
cornification can be considered a true programmed cell death pathway 
(Kroemer et al., 2009).  
 
Apoptosis 
Apoptosis is therefore considered a sub-class of the broader 
classification of programmed cell death, which includes several different cell 
“suicide” routes. There are several distinct molecular pathways, such as the 
“intrinsic” and “extrinsic” signaling pathways that can lead to the morphological 
changes associated with apoptosis.  Despite the morphological similarities 
between apoptosis associated with these two pathways they are triggered by 
very different biochemical routes.  Activation of both pathways results in 
similar cellular morphologies, because they both converge at the activation of 
the effector caspases.  Effector caspases, such as caspase-3, are proteases 
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which actively degrade cellular components or activate other lytic enzymes 
(such as the caspase-dependent DNase) that lead to the morphological 
changes associated with apoptosis (dos Santos et al., 2008). The extrinsic 
pathway of apoptosis is typically associated with cell removal during 
development, differentiation and tissue remodeling (Ferri and Kroemer, 2001) 
and is activated by death receptors on the cell’s surface that belong to the 
tumor necrosis factor receptor (TNFR) superfamily (dos Santos et al., 2008).  
Activation of the extrinsic pathway typically leads to the activation of caspase-
8, an initiator caspase that activates the effector caspases such as caspase-3.  
The intrinsic apoptotic pathway is triggered by disruptions to a cell’s internal 
homeostasis by various stressors such as an increase in reactive oxygen 
species, hypoxia, anoxia, xenobiotics, viral or bacterial proteins, or 
accumulation of misfolded proteins (Ferri and Kroemer, 2001).   This pathway 
is regulated by the Bcl-2 family of proteins and is characterized by 
mitochondrial membrane permeabilization that results in the release of pro-
apoptotic molecules into the cytoplasm, and the subsequent activation of the 
initiator caspase-9 (dos Santos et al., 2008; Kroemer and Reed, 2000). 
 
The role of caspases in cell death 
Caspases were long thought to be essential modulators in programmed 
cell death.  A growing body of evidence, however, has shown that cell death 
can still occur even when caspsase activity is inhibited (Green and Kroemer, 
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1998).  Rather, alterations in mitochondrial membrane function and stability 
can better predict cell fate (Green and Kroemer, 1998).  
While many studies demonstrate the necessity of caspases for certain 
types of cells to execute programmed cell death (McCall and Steller, 1997; 
Nicholson and Thornberry, 1997; Rodriguez et al., 1996; Song et al., 1997; 
Xue and Horvitz, 1995), there are numerous examples in the literature 
demonstrating programmed cell death that occurs independent of caspase 
activation (Amarante-Mendes et al., 1998; Brunet et al., 1998; De Maria et al., 
1997; Hirsch et al., 1997; Lavoie et al., 1998; Lesage et al., 1997; McCarthy et 
al., 1997; Ohta et al., 1997; Sarin et al., 1997; Xiang et al., 1996).  This 
caspase-independent cell death does not appear to occur due to a lack of or 
incomplete blockage of caspase activity, but rather via an alternate 
mechanism (Green and Kroemer, 1998).  This alternate mechanism is 
believed to be mediated by a loss in mitochondrial membrane integrity that 
occurs via the opening of the mitochondrial permeability transition pore 
complex (PTPC) (Kroemer et al., 1995).  Opening of the mitochondrial PTPC 
leads to a disruption of the ∆Ψm and can also cause the release of cytochrome 
C (Ellerby et al., 1997) and apoptosis inducing factor (AIF) (Susin et al., 1997; 
Susin et al., 1996).   
AIF is a potent contributor to the caspase-independent pathway of cell 
death (Susin et al., 1999).  It is normally found in the intermembrane space of 
the mitochondria where it appears to act as a terminal electron acceptor/donor 
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(oxidoreductase) under non-apoptotic inducing conditions (Lorenzo et al., 
1999).  Upon induction of apoptosis, however, the role of AIF changes.  It 
translocates to the nucleus and the cytosol where it causes chromatin 
condensation and large-scale DNA fragmentation (Cande et al., 2002; Lorenzo 
et al., 1999).  Once in the cytosol, AIF causes a change in mitochondrial 
membrane potential, leading to the release of cytochrome c and more AIF 
which acts as a positive feedback amplification loop (Cande et al., 2002).   
Disruption of mitochondrial membrane function has indeed been shown 
to cause cell death independent of caspase activation (Brunet et al., 1998; De 
Maria et al., 1997; Hirsch et al., 1997; Lavoie et al., 1998; Lesage et al., 1997; 
Xiang et al., 1996).  Both mechanisms appear to be crucially involved in cell 
death and may not behave in a linear model in which one lies upstream or 
downstream of the other (Green and Kroemer, 1998).  Studies have shown 
that caspases can cause mitochondrial dysfunction in vitro (Marzo et al., 1998; 
Susin et al., 1997) and mitochondrial events can lead to caspase activation 
(Ellerby et al., 1997; Kluck et al., 1997; Li et al., 1997; Liu et al., 1996; Susin et 
al., 1997; Yang et al., 1997; Zou et al., 1997).  As such the linear model seems 
inconsistent with the current evidence and it has been suggested that in many 
cases the two mechanisms may act together in an amplifying circular feed-
back loop (Green and Kroemer, 1998). 
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Cell Death Analysis via TUNEL Assay 
Terminal deoxynucleotide transferase dUTP Nick End Labeling 
(TUNEL) is a well-known technique used for detecting DNA breaks or 
damaged DNA in relation to total cellular DNA.  This technique allows cells 
with high levels of DNA degradation to be identified via flow cytometry or 
fluorescent microscopy.  DNA fragmentation due to nuclease activity cannot 
be used as an exclusive means to define apoptosis but it is often associated 
with apoptosis.  For this reason, it is typically used in combination with other 
criteria as a marker of cell death.   
DNA fragments resulting from nuclease activity have 3’-hydroxyl ends 
that are easily labeled by the enzymatic addition of bromolated deoxyuridine 
triphosphate nucleotides (Br-dUTP) through the action of the enzyme terminal 
deoxynucleotidyl transferase (TdT).  A fluorescent-conjugated (FITC) antibody 
to Br-dUTP is used to detect the incorporated Br-dUTP.  Cells with significant 
amounts of antibody-labeled break sites will exhibit a high amount of 
fluorescence (TUNEL-positive) while normal cells will show very little 
fluorescence.  Cells are then stained with propidium iodide (PI), a DNA 
intercalating agent incorporated by all dead cells.  A total cell count can be 
derived from the number of PI-positive cells.  A ratio of TUNEL-positive cells 
compared to the total cell count will then determine the percent of cells that 
have undergone cell death.  
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Cell Death Analysis via Caspase Activity Assay 
Caspases are a family of cysteine proteases, or cysteine-aspartic 
proteases associated with cell death processes and inflammation.  There are 
two classes of caspases involved in apoptosis.  Initiator caspases, or apical 
caspases, activate pro-forms of effector caspases by proteolysis.  Effector 
caspases, or executioner caspases, cleave other protein substrates within the 
cell to begin the cascade of reactions that lead to programmed cell death.  The 
effector caspases are specific players in the apoptotic pathway and can 
therefore be used as markers of this process.  
Both caspase 3 and caspase 7 are members of the effector caspase 
family.  Whereas the TUNEL staining helps to determine how much DNA 
damage occurred in populations of cells, it is more difficult to elucidate the 
means of cell death.  Therefore, measuring the activity levels of effector 
caspases will inform more specifically on the process of apoptotic cell death.  
Both the intrinsic and extrinsic apoptotic pathways converge at the effector 
caspase stage (dos Santos et al., 2008) so they cannot be used to distinguish 
between these two well-known pathways.  However, they can help to 
differentiate between caspase-dependent and caspase-independent 
apoptosis. 
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Hypotheses 
The embryos of A. limnaeus are able to withstand anoxic conditions 
that would normally be lethal to most vertebrates.  Anoxia is typically a 
powerful cellular stressor and often leads to apoptosis in vertebrate cells.  It is 
unclear whether the embryos of A. limnaeus experience a large degree of cell 
death from which they are able to subsequently recover or whether they are 
able to prevent cell death during anoxia.  Two assays were employed in order 
to determine the extent to which cell death was occurring.  Both TUNEL 
staining and caspase activity assays were used as biochemical determinants 
of apoptosis.  I hypothesized that the most anoxia tolerant embryos would 
exhibit the least TUNEL positive cells in response to harmful anoxic treatment.  
Additionally, I hypothesized that the most anoxia tolerant embryos would 
exhibit the least caspase-3/7 activity in response to harmful anoxia.
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Materials and Methods 
 
TUNEL assay 
Whole embryos of A. limnaeus were exposed to a regimen of 48 hr of 
anoxia followed by aerobic recovery.  Embryos were exposed to this 
experimental protocol (as described in Chapter 1) at the following 
developmental stages:  16 days post fertilization (dpf), diapause II (DII), 4 days 
post-diapause II (dpd) and 12 dpd.  After anoxic treatment the embryos were 
allowed to recover in normoxic conditions for 0, 1, 4, and 24 hours.  The post-
diapause II samples were allowed an additional normoxic recovery time point 
of 72 hr.  Four independent sample sets were prepared for each of the four 
developmental time points.  A matched normoxic control sample was prepared 
for each set of anoxic samples.   
 To prepare embryonic cells for the TUNEL analysis, approximately 50 
to 100 embryos were transferred to a small 24mm, 500µm-mesh basket 
(Netwell™, Corning Product #3480) in a 50mm Petri dish containing 2ml of 
phosphate buffered saline (PBS).  Embryos were dissociated into cell 
suspensions using a flat-bottom glass pestle.  Cell suspensions were then 
transferred to a 1.7ml microcentrifuge tube and pelleted (300 x g, 5 min).  The 
cells were then rinsed once in PBS and resuspended in 100µl of PBS.  One ml 
of 3.7% paraformaldehyde was then added to fix the cells.  Cells were stored 
in the 3.7% paraformaldehyde overnight at room temperature.  The cells were 
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then pelleted (300 x g) and the paraformaldehyde supernatant was removed.  
Cells were rinsed once in PBS and suspended in 100µl of PBS.  One ml of 
100% methanol was then added to permeabilize the cells.  The cells were 
stored in methanol at -20°C until the day of the assay. 
A TUNEL assay kit from Phoenix Flow Systems, (APO-BRDU, AU-
1001) was used to quantify TUNEL-positive cells.  The kit was used according 
to the manufacturer’s instructions unless noted otherwise.  On the day of the 
assay, the cells were pelleted via centrifugation (300 x g) and rinsed once in 
wash buffer (Phoenix Flow Systems).  The cell pellet was resuspended in 
50µL of DNA labeling solution and the DNA labeling reaction was carried out 
at 37°C for 1 hr with shaking, followed by overnight incubation at room 
temperature with no shaking.  At the end of the DNA labeling incubation, 1 ml 
of rinse buffer was added (Phoenix Flow Systems).  Cells were then pelleted 
as above and the supernatant was removed.  The cells were resuspended in 
100µl of anti-Br-dUTP antibody solution.  Samples were incubated in the dark 
for 30 min at room temperature.  After the antibody incubation, 0.5ml of 
propidium iodide/RNase A solution (Phoenix Flow Systems) was added to 
each sample.  Samples were incubated for 30 min in the dark at room 
temperature and analyzed within three hours of staining. 
The stained samples were analyzed using fluorescent microscopy on 
an inverted microscope (Leica, DMIRB) equipped with filter sets to capture 
both green (TUNEL) and red (nuclear DNA stained with propidium iodide) 
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fluorescence. For each microscopic field of view [400X] images were captured 
at 623 nm for propidium iodide (PI) fluorescence and at 520 nm for FITC 
fluorescence.  For each sample, multiple fields of view were used to quantify 
the number of cells that were TUNEL-positive as well as the total number of 
PI-positive cells. Positive- and negative-control cells provided in the kit 
(Phoenix Flow Systems) were used to ensure that the kit reagents and 
equipment were working properly.  A species-specific positive control was 
generated by treating dissociated A. limnaeus embryonic cells at 8 dpf with 
1µM staurosporine for 24 hr.   
 
Caspase 3/7 Activity 
Caspase-3/7 activity was measured in cells harvested from whole 
embryos exposed to 48 hr of anoxia and aerobic recovery from anoxia as 
described above for the TUNEL assays at the following developmental stages: 
16 dpf, DII, 4 dpd, and 12 dpd.  After anoxic treatment the embryos were 
allowed to recover in normoxic conditions for 0, 1, 4, and 24 hr.  Four 
independent sample sets were prepared for each of the four developmental 
time points.  A matched normoxic control sample was prepared for each set of 
anoxic samples.   
 To prepare embryonic cells for the caspase analysis, approximately 50 
to 100 embryos were transferred to a small 24mm, 500µm-mesh basket 
(Netwell™, Corning Product #3480) in a 50mm Petri dish containing 1ml L-15 
 49 
media.  Embryos were dissociated into cell suspensions using a flat-bottom 
glass pestle.  For each of the anoxic recovery samples, the embryos were 
allowed to recover for the specified amount of time in normoxic conditions 
before being dissociated into cells.  Once the embryonic cells were in 
suspension, they were transferred to a 1.7ml microcentrifuge tube and pelleted 
(300 x g, 5 min).  The cells were then rinsed once in L-15 media and 
resuspended in 1ml of L-15 media.  Ten µl of each concentrated cell 
suspension was used to calculate the cell density using a disposable counting 
chamber (C-Chip #DHC-N01).  Each cell suspension was diluted to 150,000 
cells/100µl and 75,000 cells were used for each assay. 
A Caspase-Glo® 3/7 Assay kit (Promega, #G8091) was used to 
measure caspase activity in the cell suspensions.  The assay contains a 
luminogenic caspase-3/7 substrate with a tetrapeptide sequence DEVD 
(aspartic acid-glutamic acid-valine-aspartic acid).  When this reagent is mixed 
with a cell suspension it results in cell lysis and release of caspases that then 
cleave the kit reagent releasing amino-luciferin.  Amino-luciferin is a substrate 
for luciferase, which generates luminescence during its catalytic cycle. The 
luminescence produced is proportional to the amount of caspase activity. 
Caspase reagent (50µl) was added to 50µl of cell suspension and 
incubated at room temperature for one hr.  A reagent “blank” was prepared 
each day using 50µl of L-15 media and 50µl of caspase reagent.  A positive 
control was created by harvesting cells from 9 dpf A. limnaeus embryos 
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exposed to 10µM staurosporine for 24 hr. Luminescence was measured using 
a luminometer (Kikkoman model C-110).  Triplicate readings were taken of 
each sample and averaged. 
 
Data presentation and statistics 
 Graphs were prepared and statistical analyses were performed using 
GraphPad Prism 5.0 software.  Statistical significance was set at p<0.05 for all 
comparisons.  When appropriate Bonferroni’s multiple comparison test was 
used to compare individual means.  Percentage data were transformed using 
the arcsin of the square root of the proportion transformation prior to statistical 
analysis.
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Results 
 
TUNEL assay 
 The results for the TUNEL staining assay are presented in Figure 3.1.  
Representative images for typical TUNEL- and PI-positive cells are presented 
in Figure 3.2. Exposure to anoxia had no statistically significant effect on the 
proportion of TUNEL-positive cells observed within any of the developmental 
stages investigated.  While not statistically significant, in some cases exposure 
to anoxia appeared to decrease the number of TUNEL-positive cells.  The only 
exception to this pattern is in the late developing embryos at 12 dpd, which 
showed an overall increase in TUNEL-positive cells, although due to high 
variation between samples this effect is not statistically significant (one-way 
ANOVA, F(5,24)=0.85, p>0.05).  While exposure to anoxia appears to have 
little effect on the number of TUNEL positive cells, there do appear to be some 
developmental differences in the proportion of TUNEL-positive cells (Figure 
3.1).  Normoxic control diapause II embryos did have a significantly higher 
proportion of TUNEL-positive cells compared to normoxic embryos from both 
post-diapause II stages (one-way ANOVA, F(3,12)=8.55, p<0.05, Tukey’s 
Multiple Comparison Test post hoc p<0.05), but not when compared to control 
embryos at 16 dpf (one-way ANOVA, F(3,12)=8.55, p<0.05, Tukey’s Multiple 
Comparison Test post hoc p>0.05). 
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Figure 3.1.  The percent of cells that stained TUNEL-positive after exposure to 
anoxia for 4 different developmental stages. The x-axis represents time of 
aerobic recovery from anoxic treatment. A positive control (+C, 8 dpf A. 
limnaeus cells treated with 1µM Staurosporine for 24 hours) and negative 
control (-C, Phoenix Flow Systems Kit negative) were provided for each.  Bars 
represent the mean ± S.E.M. (n=3-5). One-way ANOVA analysis revealed no 
significant changes from Normoxic control values, p>0.05. 
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Figure 3.2. Representative images of the controls (top panel) and 16 dpf 
embryos (bottom panel) used to calculate the proportion of TUNEL- and PI-
positive cells. 
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Caspase 3/7 Activity 
 The results for the caspase 3/7 assay are presented in Figure 3.3.  
Overall, caspase levels were low in embryos of A. limnaeus regardless of 
treatment or developmental stage when compared to the embryos treated with 
staurosporine.  For the 16 dpf embryos activity was low and remained 
unaffected by exposure to anoxia until 24 hr of aerobic recovery where a four-
fold increase was observed (one-way ANOVA, F(4,15)=34.67, p<0.0001, 
Bonferroni post hoc, p<0.05).  The DII embryos had low levels of caspase 
activity that were unaffected by exposure to anoxia even after 24 hr of aerobic 
recovery (one-way ANOVA, F(4,15)=0.31, p>0.05). 
Caspase activity levels were higher in post-diapause II embryos 
compared to the earlier stages.  In fact, there was a general trend towards an 
increase in caspase activity as the embryos progressed through development. 
The regulation of caspase 3/7 activity following exposure to anoxia was quite 
different for post-diapause II embryos compared to the earlier stages 
examined. Immediately following anoxic treatment there was a significantly 
sharp increase in caspase 3/7 activity in the 4 dpd samples (one-way ANOVA, 
F(4,15)=20.31, p<0.0001, Bonferroni post hoc, p<0.05).  This initial increase 
dropped to control levels after 1 and 4 hr of recovery and then increased again 
after 24 hr of aerobic recovery (Bonferroni post hoc, p<0.05).  In contrast, 12 
dpd embryos exhibited a significant reduction in caspase 3/7 activity by about 
50% upon anoxic exposure (one-way ANOVA, F(4,15)=23.72, p<0.0001, 
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Bonferroni post hoc, p<0.05).  Caspase 3/7 activity remained at approximately 
this same level for 4 hr of aerobic recovery and then increased significantly to 
nearly the value observed for the normoxic sample after 24 hr of recovery 
(Bonferroni post hoc, p<0.05).
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Figure 3.3.  Caspase 3/7 activity in relative luminescence units per 75,000 
cells for each of the four developmental time points. The x-axis represents 
time of aerobic recovery from anoxic treatment in hr.  A positive control (+C, 9 
dpf embryos treated with 10µM Staurosporine for 24 hours) and a blank (-C, 
50µL media and 50 µL caspase reagent) were provided for each. Bars 
represent means ± S.E.M. (n=4). (16 dpf: one-way ANOVA, F(4,15)=34.67, 
p<0.0001) (DII: one-way ANOVA, F(4,15)=0.31, p>0.05) (4 dpd: one-way 
ANOVA, F(4,15)=20.31, p<0.0001) (12 dpd: one-way ANOVA, F(4,15)=23.72, 
p<0.0001). Asterisks represent values that differ significantly from normoxic 
control values (Bonferroni post hoc, p<0.05). 
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Discussion 
  
The embryos of A. limnaeus display varying degrees of endogenous 
anoxia tolerance during development that enable them to withstand anoxic 
conditions that would be lethal to most animals (Podrabsky et al., 2007).  This 
state is acquired gradually as embryos develop and enter into diapause II, 
peaks during diapause II and is retained up to 4 days of post-diapause II 
development.  Following this period, anoxia tolerance rapidly decreases and 
by 12 dpd the embryos have lost their long-term anoxia tolerance.  It is unclear 
whether these embryos are experiencing any cellular/DNA damage.   The aim 
of this chapter was to observe markers of cellular damage (i.e. markers of 
programmed cell death) in different developmental stages of A. limnaeus that 
differ in their tolerance of anoxia in order to quantify the amount of cellular 
damage or death that may occur as a result of exposure to anoxia. 
Two independent indicators of cell death/damage were used in this 
study, TUNEL staining and caspase-3/7 activity.  These two methods of 
assessing cell death both indicate an overall lack of anoxia-induced apoptosis 
in embryos of A. limnaeus.  Interestingly, patterns of apoptosis do not seem to 
correlate with anoxia tolerance, which suggests that blockage of apoptosis is 
only one of several mechanisms that support tolerance of anoxia in this 
species.  
 Diapause II and 16 dpf embryos exhibited very low levels of caspase-
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3/7 activity that were largely unaffected by exposure to anoxia.  In addition, 
while the proportion of TUNEL-positive cells was reasonably high for these 
embryos, there was no significant effect of treatment with anoxia on these 
levels (see discussion below with respect to the high levels of TUNEL-positive 
cells).  In contrast, post-diapause II embryos respond in a developmental 
stage-specific manner to exposure to anoxia.  Embryos exposed to anoxia at 4 
dpd exhibited an increase in caspase 3/7 activity (Fig. 3.3), but this did not 
result in a large increase in apoptotic cells (Fig. 3.1).  Embryos exposed to 
anoxia at 12 dpd exhibit a significant decrease in caspase activity that is also 
not reflected in the number of apoptotic cells.  The lack of a significant 
correlation between caspase activity and the number of presumably apoptotic 
cells suggest either a different response to anoxia in these two developmental 
stages, or the presence of other protective mechanisms that can block 
caspase activity.  It is worth noting that the overall levels of caspase activity 
are low in all cases, and thus there may be small populations of cells that are 
induced to undergo apoptosis following anoxia that are not easily identified in 
the cell suspensions used for TUNEL analysis in this study.  Future studies 
should use whole-mount embryo preparations to look for specific cells or 
tissues that might enter apoptosis in response to anoxia.    
Reduction of caspase activity may be an overall strategy that helps to 
support the extreme tolerance of anoxia observed in embryos of A. limnaeus.  
While many of the stages have low levels of caspase activity that are only 
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mildly affected by exposure to anoxia, embryos at 12 dpd actually show a 
decrease in caspase activity. These embryos have a higher basal level of 
caspase-3/7 activity, and perhaps reducing this activity is critical for survival of 
anoxia in this stage.  While 12 dpd embryos are not tolerant of long-term 
anoxia, they do still have an extraordinary ability to survive over a week of 
anoxia, despite having well developed organ systems and a relatively high 
metabolic rate compared to the other embryos investigated in this study. 
 
Developmental patterns of apoptosis 
 While there is an overall increase in the amount of caspase activity as 
development progresses, the opposite trend is observed for TUNEL-positive 
cells.  This result suggests that either caspase-independent apoptosis is highly 
prevalent in 16 dpf and DII embryos, or the TUNEL-positive cells in these 
embryos are some sort of false-positive.  TUNEL staining has been reported in 
a number of studies to not correspond to apoptosis.  It has been associated 
with gene transcription (Kockx et al., 1998), DNA repair (Kanoh et al., 1999), 
and non-apoptotic DNA damage (Fleck and Carey, 2005; Lesauskaite et al., 
2004).  Due to the consistently low numbers of TUNEL-positive cells in 
normoxic post-diapause II embryos (both 4 and 12 dpd), and a clear lack of 
response in TUNEL-positive cells in diapause II embryos exposed to anoxia, 
we feel that the high levels of TUNEL-positive cells in 16 dpf and DII embryos 
are probably due to some factor other than apoptosis or cell death.  The 
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overall low metabolism of embryos in diapause II supports this conclusion.  An 
alternative explanation of these data that assumes the TUNEL-positive cells 
are apoptotic would suggest that despite their highly depressed metabolism, 
DII embryos are vulnerable to cell death.  In this scenario, cellular damage and 
subsequent cell death is occurring during diapause.  Perhaps part of the 
protective phenomenon associated with this developmental stage is the ability 
to “sacrifice” a proportion of non-essential cells in order to cut 
energetic/metabolic costs.  While these data are interesting, additional studies 
are needed to gain further insight into this issue.  Detailed observations on the 
morphology of isolated cells from 16 dpf and DII embryos, and whole-mount 
staining of cells for apoptotic nuclei would both be useful in evaluating which 
cells might be TUNEL-positive and if they exhibit apoptotic morphology. 
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CHAPTER 4: 
Ubiquitination and SUMOylation analysis 
 
Background/Introduction 
The function of proteins can be regulated by posttranslational 
modifications.  Translated gene products are subject to many modifications, 
such as methylation, acetylation, phosphorylation, SUMOylation or 
ubiquitination, etc.  Such modifications can affect manifold processes such as 
protein-protein binding, enzyme activity, subcellular localization and protein 
stability.  Of particular interest to this study is the use of ubiquitin and the small 
ubiquitin-like modifier protein (SUMO) as protein modifiers. Specifically, the 
aim of this chapter is to investigate their possible roles in regulating protein 
activity during embryonic development and after exposure to anoxia in 
embryos of the annual killifish Austrofundulus limnaeus. 
 
Ubiquitination of proteins 
Ubiquitin, a small, 9kDa protein, is as its name suggests, a ubiquitous 
protein modifier present in eukaryotic cells; recently a homologue was 
identified in prokaryotic cells (Pearce et al., 2008).  Ubiquitin regulates several 
protein-protein interactions including protein translocation, signal transduction, 
gene transcription, and cell signaling associated with apoptosis and autophagy 
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(Mukhopadhyay and Riezman, 2007).  However, ubiquitin is best known for its 
role in the proteasomal degradation process (Ciechanover et al., 1984). The 
ubiquitin-proteasome system is the major cellular pathway for degradation and 
recycling of proteins in a cell.  A single ubiquitin protein contains seven lysine 
residues.  It is synthesized as a precursor whose C-terminus is cleaved to 
reveal a glycine residue.  This C-terminus glycine residue at the end of one 
ubiquitin moiety can then bind to any of the seven lysine residues on another 
ubiquitin molecule to form a poly-ubiquitin chain (Meller, 2009).  The multitude 
of possible ubiquitin linkages enables ubiquitination to code for a more 
complex array of modifications as compared to other posttranslational 
modification mechanisms such as phosphorylation.  A target protein can be 
mono-ubiquitinated (single ubiquitin added), poly-ubiquitinated (a chain of 
ubiquitin residues are added in either a simple linear or branched 
arrangement), or mono-ubiquitinated at multiple sites (multiple lysine residues 
of a single protein are ubiquitinated) (Hicke, 2001; Ikeda and Dikic, 2008).  It is 
not yet clear what molecular signals regulate protein ubiquitination, although 
some studies have shown a complex crosstalk between protein ubiquitination 
and phosphorylation (i.e. the pro-apoptotic protein Bim) and ubiquitination and 
hydroxylation (i.e. the hypoxia induced transcription factor HIF-1) (Hunter, 
2007). 
The specific structure of the poly-ubiquitin chain can give rise to 
different functions.  For example, lysine 48 poly-ubiquitin chains (K48 links) 
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are associated with the targeting proteins to the proteasome, (Pickart and 
Cohen, 2004) and K63-linked polyubiquitin chains have been shown to target 
proteins for autophagic processing in lysosomes (Ikeda and Kerppola, 2008).  
Ubiquitin is conjugated to its target protein substrate via three linked 
reactions (Hershko, 1983).  In the first step, ubiquitin is bound to an E1 
ubiquitin-activating enzyme, forming a high-energy thioester bond.  This is the 
only step that requires ATP (Pickart, 2001).  Then the ubiquitin is transferred 
to an E2 ubiquitin-conjugating enzyme.  The final step requires an E3 ubiquitin 
ligase enzyme that catalyzes an isopeptide bond between a lysine on the 
target protein and glycine residue on the C-terminus of the ubiquitin (Meller, 
2009).  There are two main families of E3 ligases, the HECT domain 
(homologous to the E6-AP carboxyl terminus) and RING (really interesting 
new gene).  Recent studies have also identified additional E3 ligases (Jiang et 
al., 2001; Wertz et al., 2004).  While there is only one E1 protein, there are 20 
E2 conjugating enzymes, and probably hundreds of E3 ligases encoded in the 
human genome (Meller, 2009). Recent studies have revealed even greater 
complexity regarding the ubiquitination of target proteins.  Distinct E2 
conjugating enzymes are utilized depending on whether the target protein is to 
be mono-ubiquitinated or poly-ubiquitinated (Rodrigo-Brenni and Morgan, 
2007; Windheim et al., 2008).  In addition, a fourth class of enzyme, the E4-
ligase, has been suggested to regulate poly-ubiquitin chain extension (Koegl 
et al., 1999).  The number of these enzymes present and the complexity of 
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their regulation are currently unknown in annual killifish. 
A number of studies have examined protein ubiquitination in response 
to ischemic or anoxic conditions (Meller, 2009).  These studies have 
demonstrated that proteins are ubiquitinated following harmful ischemic 
conditions in rat brain (Liu et al., 2005b; Liu et al., 2004).  Interestingly, they 
showed that proteins in the post-synaptic dendrite are ubiquitinated, which 
suggests a change in neuronal morphology or synaptic function following 
ischemia.  Preconditioning the brain with a low dose of ischemia, resulted in a 
reduction in protein ubiquitination after a subsequent and normally harmful 
ischemic episode (Liu et al., 2005a).  Proteasome inhibitors have been shown 
to be protective in models of stoke (Williams et al., 2004; Williams et al., 2003; 
Wojcik and Di Napoli, 2004).  In contrast, a preconditioning dose of ischemia 
has been shown to increase protein ubiquitination in rapid ischemic tolerance 
models, and blocking the proteasome blocks rapid ischemic tolerance (Meller 
et al., 2008).  Thus, the role of ubiquitination in tolerance of oxygen deprivation 
is likely context dependent, and different amounts of cellular stress may alter 
the role of protein ubiquitination in mediating cell survival. 
 
SUMOylation of proteins 
A protein related to ubiquitin, the “small ubiquitin-like modifier” or SUMO 
can be added to proteins to regulate a variety of processes including gene 
expression, chromatin structure, signal transduction, nuclear transport, cell 
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signaling, plasma membrane depolarization, and maintenance of the genome 
(Hay, 2005; Johnson, 2004; Kerscher et al., 2006; Scheschonka et al., 2007; 
Wilson and Rosas-Acosta, 2005).  Transcription factors are the main targets 
for SUMOylation and conjugation with SUMO proteins typically results in down 
regulation of gene expression (Girdwood et al., 2004). There are four SUMO 
paralogues in vertebrates, SUMO-1 through SUMO-4 (Cimarosti et al., 2008).  
SUMO-4 is localized mainly in the kidneys (Bohren et al., 2004), while the 
other three are found in the brain (Cimarosti et al., 2008).  SUMO-2 and 
SUMO-3 share 96% homology and no difference in function has yet been 
identified (Hay, 2005).  SUMO-1 shares only 45% homology with SUMO-2 and 
SUMO-3 and has distinct immunoreactivity (Lapenta et al., 1997).  The activity 
and presence of SUMO-1 and SUMO-2/3 also differ in response to cellular 
stress events.  Under normal (non-stressful) conditions, there is very little free 
SUMO-1 and a large pool of free SUMO-2/3 (Saitoh and Hinchey, 2000).  In 
the event of cellular stress such as production of reactive oxygen species, 
osmotic shock, or heat shock, there is an increase in SUMO-2/3 conjugation to 
proteins, suggesting that SUMO-2/3 may play a role in regulating protein 
activity in response to cellular stress (Saitoh and Hinchey, 2000).   
Some studies suggest that SUMOylation is associated with a protective 
phenotype in models of ischemic preconditioning.  For example, an increase in 
protein SUMO-1-ylation in the brains of arctic ground squirrels has been 
reported during the torpor phase of hibernation, suggesting that SUMO-1-
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ylation may be a mechanism for neuroprotection during periods of otherwise 
lethally low levels of oxygen and glucose (Lee et al., 2007). Hibernation is an 
adaptive strategy used by many species.  During torpor, hibernating animals 
lower their body temperature, energy consumption, and blood flow to 
otherwise lethal levels, but experience no cell loss or CNS damage (Carey et 
al., 2003; Storey, 2003).  However, the exact role that protein SUMOylation 
may play in supporting survival during metabolic depression is currently 
unclear. 
In contrast to the hibernation study, increased SUMO-2/3 conjugation 
has been reported following harmful brain ischemia, using both focal and 
global ischemia stroke models (Yang et al., 2008a, b).  Another group 
investigated whether SUMO-2/3 conjugation was affected by ischemic 
preconditioning.  They observed an increase in SUMO-2/3 conjugation 
following harmful ischemia that was reduced when cells were preconditioned 
with brief ischemia prior to the harmful ischemic insult (Loftus et al., 2009).  
Interestingly, they also reported that the SUMO-2/3-ylation was strongest 
during the harmful ischemic challenge when ATP levels were depleted, rather 
than in the recovery phase following ischemia. It is therefore unclear whether 
protein SUMO-2/3-ylation is protective or simply a consequence of a harmful 
cellular event, i.e. an “insult marker.” 
 
 67 
Hypotheses 
The aim for this chapter was to determine whether protein modification 
via ubiquitination and SUMOylation occurs following exposure to anoxia in 
embryos of A. limnaeus and to determine if anoxic preconditioning could 
change any observed effect. 
I hypothesized that ubiquitin conjugation (presumably for targeting 
proteins to the proteasome) following anoxic treatment would not change in 
the anoxia tolerant embryos and that it would increase in the anoxia sensitive 
embryos.  Additionally, I hypothesized that this presumed increase in protein 
ubiquitination following anoxic treatment would be dampened by anoxic 
preconditioning. 
I also hypothesized that if increased SUMO conjugation is indeed a 
protective phenomenon, then SUMO-1 and/or SUMO-2/3 conjugation would 
increase in the anoxia tolerant embryos but not in the anoxia sensitive 
embryos in response to anoxic treatment. Additionally, I hypothesized that this 
presumed increase in protein SUMOylation following anoxic treatment would 
be heightened by anoxic preconditioning.
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Materials and Methods 
 
Immunoblot Analysis of SUMO-1, SUMO-2/3 and Ubiquitin Proteins  
To observe the role of ubiquitin, SUMO-1 and SUMO-2/3 in anoxia 
tolerance a western blot analysis was performed.  Cells were harvested from 
whole embryos at the following developmental stages:  diapause II (DII), 4 
days post-diapause II (dpd), and 12 dpd.  For the DII and 4 dpd developmental 
time-points, embryos were sampled after a harmful anoxic treatment of ½ the 
LT50 value for each of the stages (Podrabsky et al., 2007) and followed by 24 
hr of normoxic recovery from the anoxic exposure.  Embryos at 12 dpd were 
treated with two different anoxia regimes that simulate both harmful anoxia for 
this developmental stage (1/2 of the LT50; (Podrabsky et al., 2007)), and a 
“preconditioning” regime that has been previously shown to induce increased 
survival of anoxia in this stage of embryo (Riggs and Podrabsky, unpublished, 
Chapter 1).  The sampling regime for all three developmental stages used for 
the western blots is presented in Figure 4.1. Three independent sample sets 
were prepared for each of the three developmental time points (DII, 4 dpd and 
12 dpd).  A matched normoxic control sample was prepared for each set of 
anoxic samples.   
To prepare samples for western blot analysis, 50 to 100 embryos were 
transferred to a small 24mm, 500 µm-mesh basket (Netwell™, Corning 
Product #3480) in a 50mm Petri dish containing 2ml of phosphate buffered 
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saline (PBS) and protease inhibitor (Roche Complete Mini, #11836153001).  
Embryos were dissociated into cell suspensions by using a flat-bottom glass 
pestle to mash the embryos through the screen.  Cell suspensions were then 
transferred to a 1.7ml microcentrifuge tube and pelleted (300 x g, 5 min).  The 
cells were then rinsed two times in PBS with protease inhibitor to remove yolk 
proteins.  After the final rinse all the supernatant was removed and the cell 
pellet was snap-frozen in liquid nitrogen.  Samples were stored at -80°C until 
the day of analysis. 
Embryo lysates were prepared by lysing the cells in a buffer (0.1M 
NaCl, 0.02M Tris-HCl, pH 7.6, 1mM EDTA, pH 8.0, 1% NP-40) containing 
protease inhibitors (0.99 µg/ml aprotinin, 0.3 µg/ml leupeptin, 1.5 µg/ml 
pepstatin and 15 µg/ml PMSF and a phosphatase inhibitor cocktail (15 µg/ml, 
Sigma P2850) used as prescribed by the manufacturer.  Lysates were 
sonicated at 15% amplitude for 10 to 15 seconds or until homogenized 
(Branson Digital Sonifier, S-450D).  Samples were boiled for 5 min at 100°C 
prior to loading. 
Lysates were loaded on a 10% SDS-polyacrylamide gel and subjected 
to electrophoresis (115mV for ~2 hours).  Proteins were transferred onto 
PVDF membranes (30V, overnight).  The following day the membranes were 
blocked with 5% nonfat dried milk in Tris-buffered saline with 0.1% Tween 
(TBST solution) for 30 minutes on an agitator at room temperature.  After 
blocking, the membranes were incubated on a rotator with primary antibody in 
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5% nonfat dried milk/TBST solution in a sealed plastic bag for 2 hours at room 
temperature [SUMO-1 primary antibody diluted 1:1000, provided by R. Meller 
(Loftus et al., 2009), rabbit polyclonal] [SUMO-2/3 primary antibody diluted 
1:2000, provided by R. Meller (Loftus et al., 2009), rabbit polyclonal] [Ubiquitin 
primary antibody diluted 1:5000, Santa Cruz #8017 Mouse monoclonal].  
Membranes were removed from the plastic bag then washed for 5-10 minutes 
four times in TBST on an agitator at room temperature.  For secondary 
antibody incubation, membranes were again sealed in a plastic bag and 
incubated with HRP conjugated secondary antibody in 5% nonfat dried 
milk/TBST solution (anti-rabbit secondary antibody used for both SUMO-1 and 
SUMO-2/3 conjugated membranes was diluted 1:2000, Cell Signaling #7074).  
Total protein was determined using a Bradford Protein Assay according to the 
manufacturer’s instructions (Bio-rad #500-0205).  A standard curve containing 
12.5, 6.25, 3.125, 1.75 and 0 µg of BSA was used to calculate the total protein 
concentration in each of the samples.  All samples were read on a Molecular 
Devices Spectramax plate reader.  Lanes were loaded with equal amounts of 
protein (10µg for Ubiquitin blots and 25µg for SUMO-1 and SUMO-2/3 blots). 
Antigen binding was determined by chemiluminescence (Visualizer™ 
Western Blot Detection Kit – mouse, Millipore #64-201) and detected digitally 
using a digital image station (Kodak image station 2000RT) and analyzed with 
1D 3.6 software.  Protein levels (intensity) were determined digitally and 
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expressed as OD units and normalized to a standard normoxic sample loaded 
onto each gel. 
 
 
Figure 4.1. Sampling regimen for embryos exposed to anoxia and subsequent 
recovery from anoxia for western blot analysis. 
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Results 
 
Ubiquitination of proteins 
Total protein ubiquitination for diapause II, 4 dpd and 12 dpd embryos 
was measured using western blot analysis and representative blots are 
provided in Figures 4.2 and 4.3.  Quantification of these data by densitometry 
is presented in Figure 4.4 for diapause II and 4 dpd embryos and in Figure 4.5 
for 12 dpd embryos exposed to the preconditioning regimen.  An analysis of 
protein-ubiquitination of a 23kDa protein band that responded uniquely to 
anoxia is presented in Figures 4.6 and 4.7.
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Figure 4.2. Representative western blots of ubiquitin-conjugated proteins in 
three different developmental stages of A. limnaeus exposed to normoxia 
(Cont), harmful anoxia (Anox=21 days for DII, 32 days for 4 dpd, 72hr for 12 
dpd), and 24 hr of normoxic recovery (Rec).  The asterisk marks a 23kDa 
protein that appears to be differentially regulated during exposure to anoxia.  
Arrows denote free ubiquitin. 
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Figure 4.3. A representative blot of ubiquitin conjugated proteins in 12 dpd 
embryos exposed to normoxia (Con), 72 hr of anoxia (harmful anoxia, A) and 
24 hr of recovery from harmful anoxia (A/R).  The preconditioning regimen is 
presented in the last 4 lanes: 48 hr of anoxia (P) followed by 24 hr of aerobic 
recovery (P/R), and then 72hr of anoxia (P/R/A) followed by 24 hr of aerobic 
recovery (P/R/A/R).  The asterisk denotes a 23kDa protein band that appears 
to be differentially regulated in response to anoxia.  The arrow denotes free 
ubiquitin. 
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Ubiquitin-conjugated proteins increased significantly from control values 
following harmful anoxic treatment in both of the anoxia tolerant stages.  
Harmful anoxia was 50% of the LT50 value for each: 21 days for DII embryos 
and 32 days for 4 dpd embryos (DII: one-way ANOVA, F(2,6)=31.48, 
p=0.0007, Bonferroni post hoc, p<0.05) (4 dpd: one-way ANOVA, F(2,6)=8.17, 
p=0.0194, Bonferroni post hoc, p<0.05).  The response was greater, over 2-
fold, in the diapause II embryos, and it appears that ubiquitin conjugated 
proteins accumulated during anoxia in this developmental stage.  In 4 dpd 
embryos, ubiquitin conjugates did not appear to accumulate during anoxia, but 
were significantly elevated (nearly 2-fold) after 24 hr of aerobic recovery (Figs. 
4.2 and 4.4).  In the 12 dpd, the opposite effect was observed (Figs. 4.2 and 
4.4).  There was a significant decrease of 29% (one-way ANOVA, F(2,6)=7.69, 
p=0.0221, Bonferroni post hoc, p<0.05) in ubiquitin conjugates compared to 
the normoxic control.  After 24 hours of aerobic recovery, ubiquitin conjugate 
levels returned to control values. 
The 12 dpd, anoxia sensitive embryos were further tested in an anoxic 
preconditioning regimen.  Embryos were treated with harmful anoxia alone 
and compared to anoxic-preconditioned embryos subsequently treated with 
harmful anoxia (Figs. 4.3 and 4.5).  Harmful anoxia alone (72 hr) significantly 
decreased levels of ubiquitin conjugates by 29% (one-way ANOVA, 
F(6,14)=7.48, p=0.001, Bonferroni post hoc, p<0.05) immediately following 
anoxia.  Ubiquitin conjugation levels returned to approximately the levels of 
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the normoxic controls following 24 hours of aerobic recovery.  Exposure to 
harmful anoxia (72 hr) after anoxic preconditioning lowered the levels of 
protein ubiquitination by 25% relative to the normoxic control similarly to the 
non-preconditioned embryos but not significantly (Bonferroni post hoc, 
p>0.05).  There were no significant differences in ubiquitin conjugation 
following harmful anoxia or aerobic recovery between the preconditioned and 
non-preconditioned embryos.  
As a prelude to future studies to identify potential ubiquitinated proteins, 
the levels of a 23kDa band that was consistently observed were quantified.  In 
the diapause II samples the band was below the level of detection in the 
normoxic control but was visible after 48 hours of anoxia (one-way ANOVA, 
F(2,6)=1573, p<0.0001, Bonferroni post hoc, p<0.05).  Upon 24 hours of 
aerobic recovery this band once again disappeared (Figs. 4.2 and 4.6).  In 4 
dpd embryos the opposite pattern of expression was observed (Figs. 4.2 and 
4.6).  The band present in the normoxic control, dropped below detection 
levels upon 48 hours of anoxic treatment (one-way ANOVA, F(2,6)=2705, 
p<0.0001, Bonferroni post hoc, p<0.05).  The band was observed again after 
24 hours of aerobic recovery at only 81% of the normoxic control levels 
(Bonferroni, post hoc, p<0.05).  Embryos at 12 dpd exhibited a similar pattern 
of expression to the 4 dpd samples.  The band was again present in the 
normoxic control but dropped below the level of detection following anoxia 
treatment (one-way ANOVA, F(2,6)=7.30, p=0.0247, Bonferroni post hoc, 
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p<0.05).  Upon 24 hours of aerobic recovery there was an increase in band 
intensity to 44% of normoxic control levels.  Although the harmful anoxia 
treatment alone was significantly different from the normoxic control (one-way 
ANOVA, F(6,14)=4.26, p=0.012, Bonferroni post hoc, p<0.05)., there was no 
significant difference between the preconditioned and non-preconditioned 
samples (Bonferroni post hoc, p>0.05) following anoxic treatment (Fig 4.7).
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Figure 4.4. Western blot analysis of total protein ubiquitination for diapause II, 
4 dpd and 12 dpd embryos; normoxic control (Con), exposure to harmful 
anoxia (Anox=21 days for DII, 32 days for 4 dpd, 72hr for 12 dpd) and 24 
hours of normoxic recovery (Rec). Bars represent means and error bars are 
S.E.M. (n=3). (DII: one-way ANOVA, F(2,6)=31.48, p=0.0007) (4 dpd: one-way 
ANOVA, F(2,6)=8.17, p=0.0194) (12 dpd: one-way ANOVA, F(2,6)=7.69, 
p=0.0221). Asterisks represent values that differ significantly from normoxic 
control values (Bonferroni post hoc, p<0.05). Data were log transformed prior 
to statistical analysis in order to meet assumptions of normal distributions for 
one-way ANOVA. 
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Figure 4.5. The effect of anoxic preconditioning on12 dpd embryos.  Embryos 
were preconditioned with a non-harmful treatment of 48 hr of anoxia (P) 
followed by 24hr of aerobic recovery (P/R) and then subsequently exposed to 
72hr of anoxia (P/R/A) followed by 24 hr of aerobic recovery (P/R/A/R).  
Con=normoxic control, A=harmful anoxia (72hrs anoxia). Bars represent 
means and error bars are S.E.M. (n=3). (one-way ANOVA, F(6,14)=7.48, 
p=0.001). Asterisks represent values that differ significantly from normoxic 
control values (Bonferroni post hoc, p<0.05). Data were log transformed prior 
to statistical analysis in order to meet assumptions of normal distributions for 
one-way ANOVA. 
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Figure 4.6. Western blot analysis of protein ubiquitination at 23kDa band for 
diapause II, 4 dpd and 12 dpd embryos; normoxic control (Con), harmful 
anoxia (Anox=21 days for DII, 32 days for 4 dpd, 72hr for 12 dpd) and 24 
hours of normoxic recovery (Rec). Bars represent means and error bars are 
S.E.M. (n=3). (D11: one-way ANOVA, F(2,6)=1573, p<0.0001) (4 dpd: one-
way ANOVA, F(2,6)=2705, p<0.0001) (12 dpd: one-way ANOVA, F(2,6)=7.30, 
p=0.0247). Asterisks represent values that differ significantly from control 
values (Bonferroni post hoc, p<0.05). Data were log transformed prior to 
statistical analysis in order to meet assumptions of normal distributions for 
one-way ANOVA. 
NOTE: in order to keep all graphs on the same scale, DII samples were 
calculated as a % of the anoxic sample because normoxic control values were 
below detection limits. 
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Figure 4.7. Anoxic preconditioning in 12 dpd embryos does not significantly 
alter the levels of a 23kDa ubiquitin conjugate band when compared with 
exposure to harmful anoxia and subsequent 24 hr of aerobic recovery. 
Con=normoxic control, A=harmful anoxia (72hrs anoxia), A/R=harmful anoxia 
(72hrs) followed by 24 hrs recovery, P=anoxia preconditioning treatment 
(48hrs), P/R=preconditioning (48hrs) followed by 24hrs recovery, 
P/R/A=preconditioning (48hrs) followed by 24hrs recovery followed by harmful 
anoxia (72hrs), P/R/A/R=preconditioning (48hrs) followed by 24hrs recovery 
followed by harmful anoxia (72hrs) followed by 24hrs recovery.  Bars 
represent means and error bars are S.E.M. (n=3). (one-way ANOVA, 
F(6,14)=4.26, p=0.012). Asterisks represent values that differ significantly from 
normoxic control values (Bonferroni post hoc, p<0.05). Data were log 
transformed prior to statistical analysis in order to meet assumptions of normal 
distributions for one-way ANOVA. 
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SUMO-1 and SUMO-2/3 
 Total protein SUMOylation as well as individual bands for both SUMO-1 
and SUMO-2/3 were measured by western blot analysis and representative 
blots are presented in Figures 4.8 and 4.9 (SUMO-1) and Figures 4.16 and 
4.17 (SUMO-2/3).  Quantifications of these results based on densitometry are 
presented in Figures 4.10 – 4.15 (SUMO-1) and Figures 4.18 – 4.21 (SUMO-
2/3) below.
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Figure 4.8. SUMO-1 conjugated proteins in 3 developmental stages of A. 
limnaeus embryos exposed to harmful anoxia (Anox=21 days for DII, 32 days 
for 4 dpd, 72hr for 12 dpd) and allowed to recover for 24 hr (Rec).  Con = 
normoxic control embryos. The asterisks denote 30 and 75kDa protein bands 
that appear to be differentially regulated in response to anoxia. 
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Figure 4.9. A representative blot of SUMO-1 conjugated proteins in 12 dpd 
embryos exposed to normoxia (Con), 72 hr of anoxia (harmful anoxia, A) and 
24 hr of recovery from harmful anoxia (A/R).  The preconditioning regimen is 
presented in the last 4 lanes: 48 hr of anoxia (P) followed by 24 hr of aerobic 
recovery (P/R), and then 72hr of anoxia (P/R/A) followed by 24 hr of aerobic 
recovery (P/R/A/R). The asterisks denote 30 and 75kDa protein bands that 
appear to be differentially regulated in response to anoxia. 
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 There were no significant changes in total protein SUMOylation for 
SUMO-1 following harmful anoxic treatment for any of the three developmental 
stages investigated (Fig. 4.10).  The 12 dpd embryos exposed to the 
preconditioning regimen also demonstrated a similar pattern.  There were no 
significant changes in SUMO-1 conjugation following harmful anoxic treatment 
in either the preconditioned or non-preconditioned embryos (Fig. 4.11).  
In addition to the total levels of protein SUMO-1 conjugates, two bands 
that were observed at ~30 (Figs 4.12 and 4.13) and ~75kDa that appeared to 
be differentially regulated by anoxia (Figs. 4.14 and 4.15) were also quantified.  
The 30kDa band was observed in the normoxic control for the two 
developmental stages that exhibit long-term tolerance of anoxia (Fig. 4.12, DII 
and 4 dpd).  In both of these stages, the band at 30kDa disappeared 
completely after exposure to harmful anoxia treatment, however due to sample 
variability it was only considered significant in the DII samples (one-way 
ANOVA, F(2,6)=668.4, p<0.0001, Bonferroni post hoc, p<0.05).  In 4 dpd 
embryos, SUMO-1 conjugation was observed again after 24 hours of aerobic 
recovery.  In the 12 dpd embryo samples, the SUMO-1 conjugate was present 
at 30kDa (Fig. 4.12), however there was no significant change following anoxic 
treatment and subsequent aerobic recovery. 
The 12 dpd embryos exposed to the preconditioning regimen did not 
demonstrate any significant changes in SUMO-1-ylation at the 30kDa band 
(Fig. 4.13).  The band was strongly present and very close in value to the 
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normoxic control for all treatments. 
In diapause II embryos exposed to harmful anoxia, a SUMO-1 
conjugate in the 75kDa range appeared to exhibit differential changes in 
response to anoxic treatment, however, none of these changes were 
significant (Figs. 4.14 and 4.15).  For the 12 dpd samples exposed to the 
preconditioning regimen, harmful anoxia (72 hours) in the embryos did not 
change SUMO-1-ylation in the 75kDa size class area relative to the normoxic 
control.  Anoxic preconditioning did not appear to have a large affect on 
SUMO-1 conjugation in this size range in 12 dpd embryos. 
For SUMOylation by SUMO-2/3 there were no significant changes in 
the overall levels of total SUMO conjugates for any of the treatments (Figs. 
4.16 – 4.19).  In addition to the total protein SUMO-2/3-ylation, a strong band 
that was observed at ~75kDa was also quantified (Figs. 4.20 and 4.21).  For 
the anoxia tolerant, diapause II samples, SUMO-2/3-ylation increased by 50% 
in this area after harmful anoxic treatment and remained elevated after 24 
hours of aerobic recovery, however this change was not considered 
significant.  Both stages of post-diapause II embryos exhibited no significant 
changes in SUMO-2/3-ylation at 75kDa following anoxic treatment, aerobic 
recovery, or following anoxic preconditioning.
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Figure 4.10. Immunoblot analysis of total protein SUMO-1-ylation for diapause 
II, 4 dpd and 12 dpd embryos; Normoxic control (Con), harmful anoxia 
(Anox=21 days for DII, 32 days for 4 dpd, 72hr for 12 dpd) and 24 hours of 
normoxic recovery (Rec). Bars represent means and error bars are S.E.M. 
(n=3). One-way ANOVA analysis revealed no significant changes from 
Normoxic control values, p>0.05. Data were log transformed prior to statistical 
analysis in order to meet assumptions of normal distributions for one-way 
ANOVA. 
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Figure 4.11. 12 dpd embryos were preconditioned with a non-harmful 
treatment of 48 hours of anoxia and then subsequently exposed to harmful 
anoxia (72 hrs).  Con=normoxic control, A=harmful anoxia (72hrs anoxia), 
A/R=harmful anoxia (72hrs) followed by 24 hrs recovery, P=anoxia 
preconditioning treatment (48hrs), P/R=preconditioning (48hrs) followed by 
24hrs recovery, P/R/A=preconditioning (48hrs) followed by 24hrs recovery 
followed by harmful anoxia (72hrs), P/R/A/R=preconditioning (48hrs) followed 
by 24hrs recovery followed by harmful anoxia (72hrs) followed by 24hrs 
recovery.  Bars represent means and error bars are S.E.M. (n=3). One way 
ANOVA analysis revealed no significant changes from normoxic control 
values, p>0.05. Data were log transformed prior to statistical analysis in order 
to meet assumptions of normal distributions for one-way ANOVA. 
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Figure 4.12. Immunoblot analysis of protein SUMO-1-ylation at 30kDa band 
for diapause II, 4 dpd and 12 dpd embryos; normoxic control (Con), harmful 
anoxia (Anox=21 days for DII, 32 days for 4 dpd, 72hr for 12 dpd) and 24 
hours of normoxic recovery (Rec). Bars represent means and error bars are 
S.E.M. (n=3). (DII: one-way ANOVA, F(2,6)=668.4, p<0.0001) (4 dpd: one-way 
ANOVA, F(2,6)=1.36, p>0.05) (12 dpd: one-way ANOVA, F(2,6)=0.32, 
p>0.05). Asterisks represent values that differ significantly from normoxic 
control values (Bonferroni post hoc, p<0.05). Data were log transformed prior 
to statistical analysis in order to meet assumptions of normal distributions for 
one-way ANOVA. 
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Figure 4.13. 12 dpd embryos were preconditioned with a non-harmful 
treatment of 48 hours of anoxia and then subsequently exposed to harmful 
anoxia (72 hrs).  Con=normoxic control, A=harmful anoxia (72hrs anoxia), 
A/R=harmful anoxia (72hrs) followed by 24 hrs recovery, P=anoxia 
preconditioning treatment (48hrs), P/R=preconditioning (48hrs) followed by 
24hrs recovery, P/R/A=preconditioning (48hrs) followed by 24hrs recovery 
followed by harmful anoxia (72hrs), P/R/A/R=preconditioning (48hrs) followed 
by 24hrs recovery followed by harmful anoxia (72hrs) followed by 24hrs 
recovery.  Bars represent means and error bars are S.E.M. (n=3). One way 
ANOVA analysis revealed no significant changes from normoxic control 
values, p>0.05. Data were log transformed prior to statistical analysis in order 
to meet assumptions of normal distributions for one-way ANOVA. 
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Figure 4.14. Immunoblot analysis of protein SUMO-1-ylation at 75kDa band 
for diapause II, 4 dpd and 12 dpd embryos; Normoxic control (Con), harmful 
anoxia (Anox=21 days for DII, 32 days for 4 dpd, 72hr for 12 dpd) and 24 
hours of normoxic recovery (Rec). Bars represent means and error bars are 
S.E.M. (n=3). One way ANOVA analysis revealed no significant changes from 
Normoxic control values, p>0.05. Data were log transformed prior to statistical 
analysis in order to meet assumptions of normal distributions for one-way 
ANOVA. 
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Figure 4.15. 12 dpd embryos were preconditioned with a non-harmful 
treatment of 48 hours of anoxia and then subsequently exposed to harmful 
anoxia (72 hrs).  Con=normoxic control, A=harmful anoxia (72hrs anoxia), 
A/R=harmful anoxia (72hrs) followed by 24 hrs recovery, P=anoxia 
preconditioning treatment (48hrs), P/R=preconditioning (48hrs) followed by 
24hrs recovery, P/R/A=preconditioning (48hrs) followed by 24hrs recovery 
followed by harmful anoxia (72hrs), P/R/A/R=preconditioning (48hrs) followed 
by 24hrs recovery followed by harmful anoxia (72hrs) followed by 24hrs 
recovery.  Bars represent means and error bars are S.E.M. (n=3). One way 
ANOVA analysis revealed no significant changes from normoxic control 
values, p>0.05. Data were log transformed prior to statistical analysis in order 
to meet assumptions of normal distributions for one-way ANOVA. 
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Figure 4.16. Representative blots of SUMO 2/3 conjugated proteins in 3 
developmental stages of A. limnaeus embryos exposed to harmful anoxia 
(Anox=21 days for DII, 32 days for 4 dpd, 72hr for 12 dpd) and allowed to 
recover for 24 hr (Rec).  Con = normoxic control embryos. The asterisk 
denotes a 75kDa protein band that appears to be differentially regulated in 
response to anoxia. 
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Figure 4.17. A representative blot of SUMO-2/3 conjugated proteins in 12 dpd 
embryos exposed to normoxia (Con), 72 hr of anoxia (harmful anoxia, A) and 
24 hr of recovery from harmful anoxia (A/R).  The preconditioning regimen is 
presented in the last 4 lanes: 48 hr of anoxia (P) followed by 24 hr of aerobic 
recovery (P/R), and then 72hr of anoxia (P/R/A) followed by 24 hr of aerobic 
recovery (P/R/A/R). The asterisk denotes a 75kDa protein band that appears 
to be differentially regulated in response to anoxia. 
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Figure 4.18. Immunoblot analysis of total protein SUMO-2/3-ylation for 
diapause II, 4 dpd and 12 dpd embryos; normoxic control (Con), harmful 
anoxia (Anox=21 days for DII, 32 days for 4 dpd, 72hr for 12 dpd) and 24 
hours of normoxic recovery (Rec). Bars represent means and error bars are 
S.E.M. (n=3). One way ANOVA analysis revealed no significant changes from 
normoxic control values, p>0.05. Data were log transformed prior to statistical 
analysis in order to meet assumptions of normal distributions for one-way 
ANOVA. 
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Figure 4.19. 12 dpd embryos were preconditioned with a non-harmful 
treatment of 48 hours of anoxia and then subsequently exposed to harmful 
anoxia (72 hrs).  Con=normoxic control, A=harmful anoxia (72hrs anoxia), 
A/R=harmful anoxia (72hrs) followed by 24 hrs recovery, P=anoxia 
preconditioning treatment (48hrs), P/R=preconditioning (48hrs) followed by 
24hrs recovery, P/R/A=preconditioning (48hrs) followed by 24hrs recovery 
followed by harmful anoxia (72hrs), P/R/A/R=preconditioning (48hrs) followed 
by 24hrs recovery followed by harmful anoxia (72hrs) followed by 24hrs 
recovery.  Bars represent means and error bars are S.E.M. (n=3). One way 
ANOVA analysis revealed no significant changes from normoxic control 
values, p>0.05. Data were log transformed prior to statistical analysis in order 
to meet assumptions of normal distributions for one-way ANOVA. 
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Figure 4.20. Immunoblot analysis of protein SUMO-2/3-ylation at 75kDa band 
for diapause II, 4 dpd and 12 dpd embryos; normoxic control (Con), harmful 
anoxia (Anox=21 days for DII, 32 days for 4 dpd, 72hr for 12 dpd) and 24 
hours of normoxic recovery (Rec). Bars represent means and error bars are 
S.E.M. (n=3). One way ANOVA analysis revealed no significant changes from 
normoxic control values, p>0.05. Data were log transformed prior to statistical 
analysis in order to meet assumptions of normal distributions for one-way 
ANOVA. 
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Figure 4.21. 12 dpd embryos were preconditioned with a non-harmful 
treatment of 48 hours of anoxia and then subsequently exposed to harmful 
anoxia (72 hrs).  Con=normoxic control, A=harmful anoxia (72hrs anoxia), 
A/R=harmful anoxia (72hrs) followed by 24 hrs recovery, P=anoxia 
preconditioning treatment (48hrs), P/R=preconditioning (48hrs) followed by 
24hrs recovery, P/R/A=preconditioning (48hrs) followed by 24hrs recovery 
followed by harmful anoxia (72hrs), P/R/A/R=preconditioning (48hrs) followed 
by 24hrs recovery followed by harmful anoxia (72hrs) followed by 24hrs 
recovery.  Bars represent means and error bars are S.E.M. (n=3). One way 
ANOVA analysis revealed no significant changes from normoxic control 
values, p>0.05. Data were log transformed prior to statistical analysis in order 
to meet assumptions of normal distributions for one-way ANOVA. 
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Discussion 
A number of studies have examined protein ubiquitination and 
SUMOylation in response to ischemic, anoxic conditions and following 
ischemic preconditioning.  There is still a discrepancy as to the nature of 
ubiquitin and SUMO conjugation in response to these cellular stressors.  It is 
unclear whether the observed changes confer a protective phenotype or 
whether they are simply responses or “markers” of harmful cellular stress.  
The embryos of Austrofundulus limnaeus, which possess a unique period of 
endogenous anoxia tolerance as well as periods of anoxia sensitivity provide 
an excellent model for gaining greater insight into this developing story.   
The aim for this chapter was to determine whether there were changes 
in ubiquitin and/or SUMO conjugation of proteins following anoxia treatment in 
killifish embryos and whether or not anoxic preconditioning could change any 
observed effect in response to anoxia. 
 
Ubiquitination 
 Changes in protein ubiquitination following anoxic treatment were 
clearly evident and were different in stages that exhibit long-term tolerance of 
anoxia as compared to those with relatively less anoxia tolerance. In the two 
anoxia tolerant stages, ubiquitin conjugation was significantly increased 
following anoxia treatment.  In the earlier diapause II stage, this increase was 
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observed immediately following exposure to harmful anoxia.  In the 4 dpd 
embryos a similar increase was observed, however, it occurred following 24 
hours of aerobic recovery after the anoxic treatment.  The opposite pattern of 
expression was observed in the anoxia sensitive, 12 dpd embryos.  There was 
a significant decrease in ubiquitin conjugation observed following anoxia 
treatment.   
 The individual band quantified at 23kDa also showed some interesting 
changes following anoxic treatment.  The dormant, diapause II embryos 
exhibited non-detectable levels of this ubiquitin conjugate during normoxia.  
Following harmful anoxic treatment (21 days), however, a significant increase 
in this ubiquitin conjugate was observed.  The two post diapause stages 
exhibited the opposite pattern of expression.  This ubiquitin conjugate was 
constitutively expressed in both of these later embryonic stages and was 
reduced to non-detectable levels upon harmful anoxic treatment, suggesting 
that this ubiquitin conjugate is indeed responding to anoxic treatment in a 
developmentally specific manner that is related to the degree of endogenous 
anoxia tolerance exhibited by each stage.  Identification of this target of 
ubiquitin conjugation will be an important follow-up study for further 
investigating this phenomenon. 
Taken together, these data suggest that there is an anoxia related 
change in protein ubiquitination occurring in killifish embryos.  During the 
periods of development when the embryos are at the peak of their 
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endogenous anoxia tolerance, proteins are labeled in far greater numbers in 
response to anoxic conditions.  When this endogenous tolerance 
diminishes/disappears, proteins are instead being de-ubiquitinated or 
degraded.  This difference in ubiquitination may be explained in two ways.  
First, it is possible that in the embryos that exhibit long-term tolerance of 
anoxia, protein degradation is controlled at the level of the 26S proteasome, 
and thus ubiquitin conjugates accumulate during exposure to anoxia.  In the 
much less tolerant 12 dpd embryos, ubiquitin conjugates may be degraded 
more quickly due to less stringent control over the 26S proteasome under 
oxygen stress, or alternatively rates of ubiquitin conjugation may be reduced.  
We cannot discern between these two options without further experimentation 
and manipulation of the system. 
The second reason for this difference in ubiquitination expression 
between the anoxia tolerant and anoxia sensitive stages may not have 
anything to do with a protective phenotype.  The increase in ubiquitination of 
proteins in the diapause II and 4 dpd embryos exposed to anoxia may simply 
be due to a build up of proteins labeled for degradation that are accumulated 
during this energetically limited period.  Degradation of proteins and recycling 
of the ubiquitin molecules requires additional energy, which may not be in 
sufficient supply during anoxic conditions.  The 12 dpd embryos that have 
resumed development and are metabolically active may have sufficient energy 
to degrade proteins via the proteasome system.  An interesting follow-up study 
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might include an investigation of proteasome inhibitors in each of these 
sample sets to see if these changes in ubiquitination are affected by blocking 
proteasomal degradation.   
Preconditioning did not appear to have an effect on protein 
ubiquitination.  There was no significant difference between the preconditioned 
and non-preconditioned embryos treated with harmful anoxia.  These data 
taken together with those from the previous sample sets, indicate that changes 
in the overall levels of total ubiquitin conjugates are not related to a protective 
phenotype but rather are indications of cellular stress in this system. 
 
SUMOylation 
Previous studies have shown increases in SUMO conjugation following 
periods of ischemia or anoxia.  In some cases the increases appear following 
natural states of anoxia tolerance such as in torpor during hibernation in arctic 
ground squirrels (Lee et al., 2007).  In other cases the increase follows periods 
of harmful ischemia such as in modeled stroke (Cimarosti et al., 2008; Yang et 
al., 2008a, b).  Therefore the aim was to observe any changes in SUMOylation 
following anoxia treatment in both anoxia tolerant and anoxia sensitive stages 
of A. limnaeus embryos and to determine if anoxic preconditioning had any 
affect on any observed changes.   
This study did not indicate any significant changes in total levels of 
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either SUMO-1 or SUMO-2/3 conjugates following anoxia treatment.  This was 
true for both the anoxia tolerant as well as the anoxia sensitive embryos 
tested.  Further, there were no significant differences in preconditioned 
embryos as compared to the non-preconditioned embryos in their response to 
harmful anoxia treatment.  There were however, some changes in the 
individual band analyses for SUMO-1 but not for SUMO-2/3.  Individual 
SUMO-1 conjugates at 30 and 75kDa showed some significant changes in 
response to harmful anoxic treatment.  The 30kDa SUMO-1 conjugate was 
constitutively expressed in all three embryonic stages.  Following anoxic 
treatment, however, it dropped to undetectable levels in the two anoxia 
tolerant stages, diapause II and 4 dpd.  In the anoxia sensitive, 12 dpd 
embryos the levels were unaffected by anoxic treatment.  Similarly, the 75kDa 
SUMO-1 conjugate was constitutively expressed in all three embryonic stages.  
It also decreased following anoxic treatment but only in the diapause II 
embryos and the change was not statistically significant.  Taken together 
these data suggest that while widespread total protein SUMOylation might not 
play a significant role in response to anoxia, there are perhaps a few specific 
targets of SUMOylation that may be involved in this phenomenon.  Again, 
identification of these specific SUMO conjugates is an important follow-up 
study for further investigating this trend.
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CHAPTER 5: 
Summary and future directions 
 
The aim of this project was to observe and analyze molecular changes 
associated with anoxia both during quiescence and under conditions of 
induced tolerance in the embryos of Austrofundulus limnaeus.  Embryos of this 
species exhibit both anoxia tolerant and anoxia sensitive stages of 
development, which make them an excellent model for characterizing and 
quantifying such changes.  Understanding the molecular mechanisms 
promoting A. limnaeus anoxia tolerance is expected to aid in identifying novel 
therapeutic targets to reduce cell death following periods of anoxia or ischemia 
in heart, brain or other tissues.   
Several different methods were utilized in this study to elucidate the 
mechanisms for anoxia tolerance in the embryos of A. limnaeus including a 
cell cycle analysis, immunoblot analyses of two cell cycle regulators, cell death 
analysis using TUNEL and caspase assays and finally an analysis of protein 
post-translational modification.   
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Major findings from Chapter 2:  Cell cycle and cell cycle arrest 
 
Flow cytometry analysis of cell cycle arrest 
Cell cycle arrest was investigated using flow cytometry.  I hypothesized 
that the anoxia-tolerant stages of embryonic development would be composed 
of cells arresting mostly in G1.  This study showed  that nearly all stages of 
embryonic development were composed almost exclusively of cells in G1 and 
that these cells arrested exactly where they were in the cell cycle when treated 
with anoxia.  This strategy could be considered adaptive for several reasons.  
First, G1 cells have only one copy of their genome to maintain during this 
energy-limited state.  Second, when recovering from anoxic conditions the 
amount of DNA damage that has accumulated during anoxia will be far less to 
repair in a single copy than in two copies.   
These findings differ from those of zebrafish.  Zebrafish embryos 
exposed to anoxia arrest mostly in S (77.7%) and G2/M (22.3%) (Padilla and 
Roth, 2001).  Wild zebrafish embryos may not be routinely exposed to anoxic 
conditions and as such are not necessarily adapted for hypoxic or anoxic 
conditions.  On the other hand, annual killifish are routinely exposed to such 
conditions. 
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Immunoblot analysis of Cyclin D1 levels 
As a second component of the cell cycle analysis in A. limnaeus 
embryos the roles of two known regulators of the cell cycle, Cyclin D1, a 
positive regulator, and p53, a transcription factor that can negatively regulate 
cell cycle progression were investigated.  Western blot analysis was used to 
measure the levels of each of these proteins in A. limnaeus embryos from 
different developmental stages. 
It was expected that cyclin D1, a positive regulator of cell cycle 
progression would decrease under anoxic conditions; however, no significant 
trends in response to anoxia treatment or with anoxic preconditioning were 
observed.  It should be noted though that cyclin D1 is only one of several 
subunits that regulate the cyclin dependent kinases (CDK’s) throughout cell 
cycle progression through G1.  From this study it appears that a reduction in 
cyclin D1 is not a mechanism for regulating cell cycle arrest.  There are of 
course numerous other components to the cell cycle machinery that could be 
screened as possible regulators of cell cycle arrest that play a major role 
during anoxic conditions in A. limnaeus cells. 
 
Immunoblot analysis of p53 levels 
The second cell cycle regulator investigated was p53, which acts as a 
cellular stress sensor to halt cell cycle progression under conditions of cellular 
stress such as anoxia or when DNA damage is present.  I hypothesized that 
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p53 levels would increase following anoxic treatment, thereby negatively 
regulating cell cycle progression.  This hypothesis held true for the diapause II 
samples in which p53 expression was nearly undetectable in normoxic 
embryos and increased significantly following harmful anoxic treatment (21 
days).  These data suggest that p53 is indeed acting to arrest cell cycle in 
response to harmful anoxia in this stage of embryo as hypothesized. 
Interestingly the above pattern was reversed in the 4 dpd and 12 dpd 
embryos counter to the hypothesis.  p53 was constitutively expressed in the 
normoxic control for both of these sets of embryos, which have resumed 
development.  Although the changes were not statistically significant, there 
was a noteworthy trend in both sets of embryos following harmful anoxic 
treatment.  The high,p53 levels were reduced by ~50% in both sets of 
embryos following harmful anoxic treatment and had returned to approximately 
the normoxic values following 24 hours of aerobic recovery.  These data 
indicate that p53 is not acting as a negative regulator of cell cycle progression 
in response to harmful anoxia during the post-diapause II developmental 
stages.   
Typically when cells are deprived of oxygen or exposed to other DNA 
damaging treatments such as ultraviolet light or gamma rays, they raise their 
levels of p53 by blocking its degradation (Alberts et al., 2008).  During 
diapause II, this was the case.  As embryos rapidly lose their endogenous 
anoxia tolerance following diapause, endogenous p53 levels may act as a 
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protective mechanism that leaves cells essentially “primed” for anoxic stress 
through higher basal (normoxic) p53 expression.  The elevated basal 
(normoxic control) levels of p53 observed in the two post diapause stage 
sample sets may, however, be attributed to p53’s role in DNA repair (Sarasin 
and Dessen, 2010; Smith et al., 1995; Wang et al., 1995).  This alternate 
function of p53 may be an important mechanism for repairing damage that 
accumulated during diapause II.  The half-life of p53 is very short and as such, 
unstressed cells do not typically express constitutive levels of p53. However, 
one study has reported elevated levels of unique subspecies of human wild-
type p53 in normal cells (Rivas et al., 1992).  Depending on the degree of DNA 
damage accrued during the anoxic period, p53 may act to halt cell cycle 
progression, or if the damage is too great, induce apoptosis once normoxic 
conditions are established. 
 
 
Major findings from Chapter 3:  Cell death analysis 
Embryos of A. limnaeus are able to withstand long periods of oxygen 
deprivation as well as many other forms of cellular stresses.  It is unclear 
whether the cells of these organisms experience significant DNA damage in 
response to stressors but are able to repair the damage or whether they are 
able to prevent DNA damage from accruing in the first place.  One of the aims 
of this study was to determine whether any such damage was occurring by 
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measuring two known markers of DNA damage that typically lead to 
programmed cell death.   
 
TUNEL analysis 
The first marker for DNA damage that I used, Terminal deoxynucleotide 
transferase dUTP Nick End Labeling (TUNEL), is a well-known technique for 
detecting DNA breaks or damaged DNA in relation to total cellular DNA.  
TUNEL staining was measured in four different embryonic developmental 
stages representing both anoxia tolerant and anoxia sensitive embryos.  
Staining was quantified using fluorescent microscopy. 
Although none of the changes observed in TUNEL staining were 
significant there were some interesting trends.  It was clear that that the anoxia 
sensitive group of embryos tested (12 dpd) exhibited the greatest degree of 
TUNEL-positive cells in response to anoxia treatment.  For the other three 
groups of embryos, 16 dpf, diapause II and 4 dpd, all associated with 
increasing or peak anoxia tolerance, there was a decrease in TUNEL positive 
cells in response to anoxia treatment, indicating that these embryos are 
perhaps able to prevent DNA damage during periods of anoxia.   
Another notable finding was that the highest basal level of TUNEL 
positive cells (i.e. normoxic control samples) was observed in the diapause II 
samples.  These embryos are in a state of suspended animation and are at 
the peak of their endogenous anoxia tolerance.  They are also, however, 
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severely energy-limited.  This lack of energy may partly account for the 
accumulation of TUNEL positive cells observed in these samples.  However, 
even in this energy-limited state, the proportion of TUNEL positive cells still 
decreased (as did the other two anoxia tolerant stages of embryos) albeit not 
to a significant degree.   
These interesting trends warrant further investigation with larger sample sizes 
to improve statistical power.   
 
Caspase-3/7 analysis 
DNA fragmentation due to nuclease activity (i.e. TUNEL staining 
assays) cannot be used as an exclusive means to define apoptosis but it is 
often associated with apoptosis.  For this reason, it is typically used in 
combination with other criteria as a marker of cell death.  Another indicator of 
apoptosis used in this study was caspase-3/7 activity. There are two classes 
of caspases involved in apoptosis.  Initiator caspases, or apical caspases, 
activate pro-forms of effector caspases by proteolysis.  Effector caspases, or 
executioner caspases, cleave other protein substrates within the cell to begin 
the cascade of reactions that lead to programmed cell death.  The effector 
caspases are specific players in the apoptotic pathway and can therefore be 
used as markers of this process.  Both caspase 3 and caspase 7 are members 
of the effector caspase family and were evaluated together for their role in 
caspase-dependent apoptosis in A. limnaeus embryos in response to anoxic 
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treatment.  Caspase-3/7 activity was measured in four different embryonic 
developmental stages representing both anoxia tolerant and anoxia sensitive 
embryos. 
For the three stages of anoxia tolerant embryos (16 dpf, diapause II, 
and 4 dpd) the basal or normoxic control levels of caspase-3/7 were low, 
indicating very little caspase-dependent apoptosis.  In response to anoxia, the 
diapause II embryos, which are in a state of suspended development and are 
at the peak of their endogenous anoxia tolerance, exhibited no significant 
change in their already low levels of caspase.  In the other two anoxia tolerant 
stages of embryos, both the 16 dpf (prior to entering diapause II) and the 4 
dpd (just exiting diapause II), basal levels of caspase activity were also low but 
showed a significant increase with anoxic treatment.  These increases 
occurred either immediately following anoxic treatment (4 dpd) or after 24 
hours of subsequent aerobic recovery (16 dpf).  Although both of these 
increases were statistically significant they were still much lower (5 fold lower) 
than the positive control (i.e. a sample treated with Staurosporine, a known 
apoptosis inducer).  Taken together, these data suggest that the naturally 
anoxia tolerant stage embryos that are not in diapause II are possibly 
vulnerable to some caspase dependent apoptosis in response to anoxic 
conditions.  However, given the magnitude of caspase activity in a sample 
treated with a known apoptotic-inducing agent (i.e. the Staurosporine treated 
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positive control) it is unlikely that observed caspase activity leads to significant 
amounts of cell death in A. limneaus. 
In the 12 dpd embryos, which were the most anoxia sensitive stage 
tested, basal caspase levels in the normoxic samples were higher, although 
they were still nearly 4-fold lower than the positive control.  In response to 
anoxic treatment these levels initially decreased but rose again to the higher 
normoxic levels following 24 hours of subsequent aerobic recovery.  Not 
surprisingly, these data indicate that these anoxia-sensitive embryos are 
indeed more vulnerable to caspase-dependent apoptosis during anoxic 
conditions than the other, earlier-stage and more anoxic tolerant embryos 
tested.  Despite the slightly heightened vulnerability to anoxic treatment in 
these 12 dpd embryos, it should be noted that these embryos still retain a 
remarkable ability to withstand anoxia (LT50 = 7.4 ± 0.7 days, Fig 2.2), which is 
reflected by the overall low caspase activity relative to the positive control. 
 
Major findings from Chapter 4:  Ubiquitination and SUMOylation analysis 
The function of proteins can be regulated by post-translational 
modifications.  Changes in SUMO (small ubiquitin-like modifier) and ubiquitin 
modifications to proteins have been associated with ischemia and anoxia in 
several studies.  It is still unclear whether these changes are protective or 
simply markers of cellular stress and damage. 
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The final aim of this study was to observe post-translational protein 
modifications in A. limnaeus embryos in response to anoxic treatment.  
Immunoblot analysis was used to measure the levels of ubiquitin, SUMO-1 
and SUMO-2/3 in three different embryonic developmental stages 
representing both anoxia tolerant and anoxia sensitive embryos. 
 
Immunoblot analysis of Ubiquitin 
 Of the three post-translational modifiers tested, ubiquitin showed the 
greatest response to anoxic treatment.  In the anoxia tolerant diapause II 
samples there was a significant increase in total ubiquitinated protein 
immediately following anoxic treatment.  Additionally, there was a significant 
increase in a specific 23kDa ubiquitin conjugate in the diapause II embryos 
following harmful anoxia.  In the 4 dpd embryos, which still retain their peak 
anoxia tolerance, there was also a significant increase in total protein 
ubiquitination following anoxic treatment, however, this increase was only 
evident following 24 hours of aerobic recovery. The anoxia sensitive 12 dpd 
embryos exhibited the opposite pattern of expression with a significant 
decrease in total protein ubiquitination following anoxic treatment.  The 23kDa 
ubiquitin conjugate also exhibited a significant decrease following harmful 
anoxia in both the 4 and 12 dpd embryos.  These results may indicate that 
embryos in diapause II allow damaged proteins to accumulate during 
diapause and process them upon exit from dormancy, while embryos at 4 and 
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12 dpd block ubiquitination of proteins during exposure to anoxia in order to 
conserve cellular ATP stores for processes that immediately contribute to the 
survival of the cell.  
Taken together these data suggest that posttranslational protein 
modification by ubiquitin is occurring in the anoxia tolerant embryos of A. 
limnaeus.  Perhaps an adaptive strategy for surviving anoxic conditions is to 
label all non-critical cellular components for proteasomal degradation. 
 
Immunoblot analysis of SUMO-1 and SUMO-2/3 
 Total protein conjugation by both SUMO-1 and SUMO-2/3 showed very 
little response to anoxic treatment in each of the three stages of embryos.  
There were a few individual SUMO-1 protein conjugates however, that did 
respond differentially to anoxic treatment.  A 30kDa SUMO-1 conjugate 
decreased significantly following harmful anoxic treatment in the diapause II 
embryos.  Another 75kDa SUMO-1 conjugate also demonstrated a decrease, 
albeit not significant, following harmful anoxic treatment in the diapause II 
embryos.  These data indicate that while widespread SUMO-1-ylation is not 
responsive to harmful anoxia there may be some specific SUMO-1 targets 
involved in responding to anoxic stress in A. limnaeus embryos.  The specific 
SUMO targets affected by the anoxic treatments in this study represent 
potentially interesting avenues to pursue in future studies and identifying them 
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may help to better elucidate the role of SUMOylation in response to cellular 
stress. 
 
Final thoughts and future directions 
 The overall findings from this study indicate that the embryos of A. 
limnaeus do indeed experience some degree of cellular stress (i.e. increase in 
ubiquitinated proteins, increase in p53 expression, evidence of DNA damage 
from TUNEL staining and increases in caspase activity) in response to anoxic 
treatment, even in their most protective state of diapause II.  However, despite 
these observations, the whole organisms are still able to recover from anoxia 
and do not succumb to death.  The overall low levels of TUNEL-positive cells 
and caspase activity relative to the positive controls indicates that the damage 
accrued in response to anoxic treatment is minimal.  It appears that embryos 
are able to either “sacrifice” a certain portion of cells or they are able to repair 
the damage required for resumed development following anoxia.   
 One important follow up study would be to investigate the role of the 
proteasome in this system.  For instance, are the increases in protein 
ubiquitination indeed targets for proteasomal degradation or do they play a 
different role?  What are the specific target proteins of this observed increase?  
Are they mono- or poly-ubiquitinated?   
 Another interesting follow up study would be to repeat the TUNEL 
experiment.  There were several interesting trends suggesting that the 
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embryos are able to block DNA damage, however, none of these changes 
were significant.  Further studies with larger samples or more repeats may 
shed light on these observed trends.  Additionally, a morphological analysis for 
apoptotic cells following TUNEL staining in both dissociated cells and whole 
mount embryos would be an important study. 
This study only touches the surface of the question as to how these 
amazing animals survive such extreme environmental conditions that would be 
lethal to most eukaryotes.  There is of course a multitude of molecular 
machinery that may be involved and it is exciting to imagine the discoveries 
that are yet to be made using this remarkable model species. 
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CHAPTER 6: 
 
Establishing an embryonic cell line from Austrofundulus limnaeus 
 
Background/Introduction 
Embryonic stem cells are undifferentiated cells derived from early 
embryos that have the potential to develop into any adult cell phenotype.  
Embryonic stem cells (ESCs) have piqued intense scientific interest due to 
their enormous potential as both a research tool and as a mechanism for 
disease therapy.  ESCs have been isolated from a number of vertebrates 
including mammals, birds and fish (Alvarez et al., 2007; Bejar et al., 2002; 
Chen et al., 2003a; Chen et al., 2003b; Chen et al., 2004; Evans and 
Kaufman, 1981; First et al., 1994; Hong and Schartl, 1996; Iannaccone et al., 
1994; Martin, 1981; Pain et al., 1996; Piedrahita et al., 1990; Sukoyan et al., 
1993; Thomson et al., 1995; Wheeler, 1994).  Specifically, fish ESCs offer 
several advantages to other vertebrate stem cell lines.  Fish embryos are large 
and transparent, develop rapidly, can be produced in large quantities and are 
simple to harvest in contrast to mammalian and avian species.  Fish models 
for vertebrate development and physiology such as the zebrafish (Danio rerio; 
(Fishman, 2001)) and medakafish (Oryzias latipes) (Wittbrodt et al., 2002)) are 
comparable to the widely used mouse models for gene function studies.  Fish 
embryonic stem cell cultures have also been shown to be advantageous for 
their independence of differentiating inhibitors (Alvarez et al., 2007). 
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Annual killifish species have many unique developmental qualities that 
would make them an ideal vertebrate model for the study of development and 
gene function.  Their ability to enter diapause during embryonic development 
and sustain a variety of harsh environment conditions as well as their unique 
dispersion-reaggregation phase that is interposed between cleavage and 
embryogenesis, makes this species an excellent source for an in vitro 
comparative model.  The aim of this project was to isolate and characterize an 
embryonic stem cell line from the Annual killifish species, Austrofundulus 
limnaeus and to determine the environmental parameters in which this cell line 
can survive.  
 
Austrofundulus limnaeus’ unique development 
The annual killifish, Austrofundulus limnaeus is a cyprinodont fish 
endemic to ephemeral ponds in regions of northern South America where it is 
most commonly found in the Maracaibo basin of Venezuela (Lilyestrom and 
Taborn, 1982; Taborn and Thomerson, 1978) a region that has been 
described as having extreme fluctuations in temperature and drought 
(Podrabsky et al., 1998).  The adult and juvenile forms die out on a seasonal 
basis when their ponds desiccate during dry seasons (Nico and Thomerson, 
1989).  This severe and unpredictable climate has given rise to several unique 
developmental adaptations, including the ability to enter a profound state of 
metabolic dormancy, which allows populations of A. limnaeus to persist under 
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conditions that are lethal to almost all other species of fish (Myers, 1952; 
Wourms, 1972a, b).  During this period of developmental arrest, or diapause, 
the embryos are extremely resistant to a variety of harsh environmental 
conditions.  Rainy periods cause the ponds to refill and the embryos resume 
development, hatch and continue the life cycle (Wourms, 1972a). 
 Embryonic diapause in annual killifish was discovered in the 1960’s by 
Wourms (Wourms, 1963, 1964) and Peters (Peters, 1963, 1965) who 
described two unique characteristics of annual killifish development that 
differed substantially from that of all other vertebrates and more specifically 
from all other teleost fish.  The first major difference is the ability of annual 
killifish embryos to undergo developmental arrest at specific and well-defined 
morphological stages (Wourms, 1972c).  The second is a unique stage of 
early development that includes the complete dispersion and subsequent 
reaggregation of the cells that will generate the embryo (Wourms, 1972b). 
 Embryonic diapause is a state of profound developmental and 
metabolic arrest in annual killifish (Podrabsky and Hand, 1999).  Diapause can 
be described loosely as obligate or facultative in annual killifish, although it 
appears that all stages of diapause are in some way responsive to 
environmental influences.  In general, there are three distinct stages at which 
the embryo may enter diapause.  The first, Diapause I, is a facultative arrest.  
It occurs during stage 20 of embryonic development when the deep 
blastomeres are in dispersed phase I and occurs only when environmental 
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conditions are suboptimal (Wourms, 1972c).  Diapause II has been described 
as an obligate developmental arrest period although some embryos may 
bypass this stage depending on the temperature (Podrabsky et al., 2010).  It 
commences during stage 32 to 33 and at 25ºC almost 70-90% of the embryos 
will arrest at this stage (Wourms, 1972c).  The third period of developmental 
arrest, Diapause III, occurs during stage 43, just prior to hatching and can also 
be initiated by sub-optimal environmental conditions, although it appears to be 
obligate in our laboratory stock of A. limnaeus (Wourms, 1972c).   
 Another unique developmental distinction of annual killifish is a stage of 
complete dispersion and subsequent reaggregation that occurs during epiboly 
and has been termed the dispersion-reaggregation process (Wourms, 1963, 
1964, 1965, 1967, 1972a, b).  Normal teleost development begins with a 
series of cleavages that produce two populations of blastomeres:  peripheral 
blastomeres become multinucleate and flatten to form the enveloping cell layer 
(ECL) which is shed at hatching, and deep blastomeres which form an 
immediate aggregate and proceed through embryogenesis.  The embryos of 
annual killifish differ significantly during development by means of a unique 
phase termed the dispersion-reaggregation phase that is interposed between 
cleavage and embryogenesis (Wourms, 1972a).  During this period, the deep 
blastomeres disperse as amoeboid-like cells; there is no embryonic axis, 
embryo, or any distinct mass of tissue (Wourms, 1972a).  
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Figure 6.1a. Two populations of blastomeres evident; flat, multinucleate 
enveloping layer cells on surface and round, deep blastomeres beginning to 
disperse. 
Figure 6.1b. Deep blastomeres further dispersed in an expanding hollow 
blastula stage embryo. 
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The amoeboid-like, deep blastomeres are randomly distributed and 
increase in number, due almost entirely to mitotic divisions and rarely from 
recruitment of peripheral blastomeres (Wourms, 1972a).  At the completion of 
epiboly, the deep blastomeres are randomly dispersed and remain so for 
approximately four days (Wourms, 1972a).  At approximately four days post 
fertilization (stage 22) the blastomeres begin to aggregate, typically below the 
equator and form a mass that is shaped like a lenticular disc, wider in the 
center and as thin as a single cell layer on the periphery (Wourms, 1972a).  
This aggregate eventually forms the embryonic axis and at this stage annual 
killifish embryos follow normal teleost development (Wourms, 1972a). 
It is unknown whether the deep blastomeres of annual killifish have 
undergone gastrulation and differentiated into the three primary germ layers. 
The deep blastomeres are randomly distributed during the dispersed phase 
and do not appear to be organized into any cell layers.  There is no embryonic 
axis or any distinct cell aggregate at this stage.  Wourms (Wourms, 1972a) 
hypothesized that this phenomenon arose as a developmental adaptation.   
With this adaptation, the embryo would be capable of sustaining a tremendous 
loss of progenitor cells during this period but would remain viable with only a 
single surviving totipotent stem cell.  Although it has not been tested, it is the 
reigning hypothesis (Murphy and Collier, 1997; Wourms, 1972a)as well as our 
belief that these deep blastomeres remain either toti- or pluripotent stem cells 
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until the reaggregation phase at stage 22 of development where they coalesce 
to form the embryonic axis. 
 
Embryonic stem cell research 
Tissue culture arose at the beginning of the 20th century as a means of 
studying animal cells free from the variations that might arise during in vivo 
experimentation (Freshney, 2005).  Early on, tissue explants dominated the 
field until the early 1950’s when defined media and enzymatic techniques for 
passaging cells were developed, thereby facilitating the technique of 
dissociated cell culture (Freshney, 2005).  Cell culture has become an 
invaluable tool for numerous fields of scientific research including 
pharmacology, immunology, genomics, developmental biology, cell 
physiology, tissue engineering, toxicology, cancer research, and a myriad of 
others.  Culturing cells in vitro has several advantages such as a reduction in 
animal use, easy preservation, as well as providing a microenvironment for 
defined and controlled conditions (Freshney, 2005). 
New cell lines are continually being developed and remain a vital part of 
scientific research today.  Stem cells in particular, are advantageous for 
studying the biological function of genes (Cecconi and Meyer, 2000; Muller, 
1999) and due to their enormous potential as a research tool a great deal of 
attention has been focused on the development of protocols for stem cell 
research. 
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In addition to human ESCs, isolates have also been successfully 
cultured from a number of vertebrates including mammals, birds and fish.  The 
establishment of embryonic stem cells from mice in the 1980’s (Evans and 
Kaufman, 1981; Martin, 1981) paved the way for the development of several 
other vertebrate stem cell lines.  Similar, ESC cultures have been successfully 
established from sheep (Piedrahita et al., 1990), mink (Sukoyan et al., 1993), 
rat (Iannaccone et al., 1994), pig (Wheeler, 1994), cow (First et al., 1994), 
monkey (Thomson et al., 1995), and chicken (Pain et al., 1996). 
 Initially, embryonic stem cells from most species required growth on a 
feeder-layer of cells to avoid differentiation (Evans and Kaufman, 1981).  The 
first attempts to culture fish ESCs centered on establishing growth conditions 
that avoided spontaneous differentiation (Alvarez et al., 2007).  Culturing 
attempts in medaka and zebrafish showed the necessity of using rich media 
including fish embryo extract, and bovine fibroblast growth factor (bFGF) 
(Alvarez et al., 2007).  ESCs from both model species were cultured 
successfully using the non-differentiating strategies used for murine cells such 
as feeder layers (Evans and Kaufman, 1981), conditioning media (Martin, 
1981), and linfocine leukemia inhibitory factor (LIF) .  These cultures were 
successful on a short-term basis.  However, the results were not satisfactory 
for long-term cultures (Alvarez et al., 2007; Hong et al., 2000).   
More recently, human, mouse and some fish species have been 
cultured successfully without feeder layers.  Hong and Schartl (Hong and 
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Schartl, 1996) developed feeder-free culture conditions for medakafish, 
Oryzias latipes, that have been successfully applied to a handful of other fish 
species including gilthead seabream, Sparus aurata (Bejar et al., 2002), red 
seabream, Pagrosomus major  (Chen et al., 2003a), sea perch, Lateolabrax 
japonicus (Chen et al., 2003b), flounder, Paralichthys olivaceus (Chen et al., 
2004) and zebrafish, Danio rerio (as cited in (Alvarez et al., 2007). 
Specifically, fish ESCs offer several advantages when compared to 
other vertebrate stem cell lines.  In contrast to mammalian and avian species, 
it is relatively easy to harvest cells from fish embryos because fish embryos 
are large and transparent, develop rapidly, and can be produced in large 
quantities.  Additionally, fish models for vertebrate development and 
physiology such as the zebrafish (Fishman, 2001) and medakafish (Wittbrodt 
et al., 2002) are comparable to the mouse for use in gene function studies 
(Alvarez et al., 2007).  Additionally, fish ESCs offer an appreciable advantage 
over non-piscine species due to their independence from growth conditions 
requiring inhibitory differentiation factors or the need to be grown on feeder 
layers (Alvarez et al., 2007). 
 
 
Materials and Methods 
 
The successful model for establishing feeder-free primary cultures from 
medakafish embryos (Hong and Schartl, 1996) was employed in isolation, 
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expansion and developmental progression of stem cells from A. limnaeus 
embryos.  This protocol has been successfully applied to other diverse species 
of fish (Bejar et al., 2002; Chen et al., 2003a; Chen et al., 2003b; Chen et al., 
2004; Hong and Schartl, 1996) thereby demonstrating the feasibility of these 
techniques.  The protocol for isolating primary embryonic stem cells from A. 
limnaeus involves three major steps, 1) bleaching, 2) chorion removal and 3) 
plating of the cells.   
The first step, bleaching of the embryos, was conducted in a clean 
room inside of a laminar flow hood.  The concentration of sodium hypochlorite 
solution as well as the time in the solution were both optimized.  The optimal 
concentration settled upon was 0.2% sodium hypochlorite solution in embryo 
medium for 2 minutes. 
After the various bleaching conditions were tested, the final optimized 
protocol reads as follows:  Using a transfer pipette, embryos were transferred 
to a sterile 24mm, 500µm-mesh basket (Netwell™, Corning Product #3480) 
resting in a well of a six-well plate containing embryo medium with 10 mg/l 
gentamycin sulfate.  The Netwell™ basket was transferred to the second well 
of the six-well plate containing a solution of 0.2% bleach (prepared fresh).  A 
sterile transfer pipette was used to pipette the bleach solution over the entire 
basket and all the embryos inside for 2 minutes.  This step ensured continuous 
movement of the embryos to all allow all surface areas of the embryos as well 
as the basket to be exposed to the bleach solution.  After 2 minutes in the 
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bleach solution, the Netwell™ basket was transferred to the third and fourth 
wells of the six-well plate successively, both containing sterile calcium-free 
Ringer solution. This step was used to remove a majority of the bleach 
solution.  The Netwell™ basket containing the bleached embryos was then 
transferred to the fifth well of the six-well plate containing a sterile solution of 
1% Sodium Thiosulfate in 1x Hank’s Balanced Salt Solution to neutralize any 
remaining bleach.  The Netwell™ basket containing embryos was finally 
placed in the sixth well of the plate, containing sterile cell culture medium.
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Figure 6.2. Series of solutions used in the embryo bleaching protocol carried out 
in a sterile six-well tissue culture plate. 
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The second step, removing the chorion, was also conducted in a 
HEPA-filtered, tissue-culture room.  Embryos were dechorinated mechanically 
with sterile fine-tipped forceps using a dissecting scope or they were ground 
with a glass pestle.  The embryos ground with the glass pestle were either 
plated directly after rinsing or they were sieved through a mesh screen to 
remove any large pieces of chorion. 
After the various conditions for chorion removal were tested, the final 
optimized protocol reads as follows:  The Netwell™ basket resting in the sixth 
well of the culture plate containing cell culture medium was used to dissociate 
the cells.  A sterile glass pestle was used to gently push the embryos through 
the mesh of the basket (embryos were popped but not ground with the pestle 
and the basket was rinsed in media to aid in rinsing out cells). 
The suspension of cells was triturated through a sterile 200µL pipette 
tip several times to further dissociate cells.  The cell suspension was 
transferred to a sterile microcentrifuge tube.  Cells were rinsed 2 times in cell 
culture medium by centrifugation (300 x g for 3 to 5 minutes) to remove excess 
yolk protein.  After rinsing, the cell suspension was plated directly into tissue 
culture slides, Petri dishes or plates containing the appropriate amount of cell 
culture medium. 
The third step, plating the cells, was also conducted in a HEPA-filtered, 
tissue-culture room inside a laminar flow hood.  Several different plating 
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methods and techniques were employed and are presented in Figure 6.3 
below.  
Figure 6.3.  List of the plating techniques tested for optimization of cell culture 
with embryonic cells isolated from A. limnaeus. 
Regular, untreated tissue culture plastic 
Regular tissue culture plastic treated with 0.1% gelatin 
Lab-Tek® II CC2 – treated chamber slide 
Permanox® Plastic Lab-Tek® Chamber slide 
Permanox® Plastic Lab-Tek® Chamber slide treated with 0.1% gelatin 
Permanox® Plastic Lab-Tek® Chamber slide with 5µg/mL Laminin added to 
the cell culture medium 
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Figure 6.4. A. limnaeus deep blastomeres isolated from embryos 4 days post 
fertilization and grown in an in vitro culture. 
 
Figure 6.4a. Intact embryo 
Figure 6.4b. Dissociated cells 
Figure 6.4c. Amoeboid cells 
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Figure 6.5. Embyronic cells isolated from A. limnaeus embryos in diapause II 
at 29 days post-fertilization. 
 
Figure 6.5a. Day 0 in culture 
Figure 6.5b. Day 2 in culture 
Figure 6.5c. Day 3 in culture 
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Optimization of culture conditions 
Primary cultures were established on numerous occasions.  Optimal 
growth conditions were never achieved due to time constraints as well as 
facility unavailability.  Primary cell cultures were maintained for up to a month 
and a half, however, they did not divide adequately for passage.  Ideally, each 
component of the in vitro system would be titrated for optimum viability 
including media composition, incubation temperature, humidity, gas 
composition, and cell monolayer density.  Growth medium has been 
provisionally formulated but not optimized.  Formulations were based on the 
media compositions developed for zebrafish (Westerfield, 1995) and 
medakafish (Hong and Schartl, 1996) embryonic stem cell cultures.  (See 
Figure 6.6 for the current formulation of growth medium.)  
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Figure 6.6. Complete growth medium for A. limnaeus cell culture  
(in 500 mL L-15) 
glucose (4.5 g/L) 
HEPES (20mM) 
2-mercaptoethanol (100µM) 
fetal Bovine Serum (15%) 
fish Serum (1%) 
L-glutamine (2 mM) 
nonessential amino acids (1 mM) 
sodium pyruvate (1 mM) 
sodium selenite (1 mM) 
bFGF (2 ng/mL) 
A. limnaeus Embryo Extract (0.5 embyros/mL) 
penicillin (50 U/mL) 
streptomycin (50µg/mL) 
gentamycin (50µg/mL) 
fungizone (1mL/100mL) 
pH adjusted to 7.4 
osmolality adjusted to 296 mOs/kg 
Sterile-filtered through a 0.22µm vacuum filter 
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Figure 6.7. Examples of A. limnaeus cells maintained in culture.  Cells were 
isolated from 12 dpd embryos and maintained in culture for 25 days at 25°C. 
 
Figure 6.7a. Fibroblast-like cells 
Figure 6.7b. Contractile cardiac tissue which actively contracted for 19 days in 
culture. 
Figure 6.7c. Example of a neuronal cell in culture. 
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Figure 6.8. Examples of embryoid bodies formed in culture from embryonic  A. 
limnaeus cells. 
 
Figure 6.8a. Embryoid bodies formed from cells isolated from 4 dpf embryos. 
Figure 6.8b. Embryoid bodies formed from cells isolated from 36 dpf embryos. 
Figure 6.8c.  A close-up view of embryoid bodies formed from 36 dpf embryonic 
cells. 
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Figure 6.9. Examples of A. limnaeus cells maintained in culture. 
 
Figure 6.9a. Neuronal-like cells after 25 days in culture that were initially isolated 
from embryos at 36 dpf. 
Figure 6.9b. Fibroblast-like cells after 25 days in culture that were initially isolated 
from 36 dpf embryos. 
Figure 6.9c. Growth ring formed after 31 days in culture.  Cells were initially 
isolated from embryos at 5 dpf. 
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Assessment ESC’s for toti- or pluripotency 
Undifferentiated stem cells express specific lineage markers, which 
allow for their identification.  Additionally, the role of specific transcription 
factors in regulating early gene expression can be measured and correlated to 
developmental stage.  In order to maintain that a cell line that is indeed an 
embryonic stem cell line, the cells must be characterized.  Initially it was our 
aim to use three universally accepted markers of pluripotency expressed in 
undifferentiated cells to determine the nature of the embryonic cells in culture:  
1) Alkaline phosphatase activity, 2) OCT-4 expression and 3) SSEA 
expression.  Once it was determined that the establishing the embryonic cell 
line would be temporarily placed on hold, these experiments also were 
temporarily suspended.  Below are some preliminary data that were collected 
on Alkaline phosphatase expression in A. limnaeus embryos. 
 
Alkaline Phosphatase Activity 
Alkaline phosphatase is highly expressed in undifferentiated cells and is 
often used as a stem cell marker (Familari and Selwood, 2006). The in vitro 
alkaline phosphatase assay was performed using a commercial kit designed to 
measure alkaline phosphatase activity in embryonic stem cells (Chemicon 
International, Catalog No. SCR004).  The in vivo portion of this work has been 
completed and clearly denotes the presence of undifferentiated cells in the 
embryo at various stages.  At five days post fertilization the deep blastomeres 
 139 
are in the dispersed phase.  Many of these cells appear blue indicating they 
are indeed expressing alkaline phosphatase (Figure 6.10a).  At twelve days 
post fertilization, the deep blastomeres have started to reaggregate, while 
some remain dispersed.  Many of these cells also appear blue indicating that 
they are still expressing alkaline phosphatase activity (Figure 6.10b).
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Figure 6.10. Alkaline phosphatase staining in whole A. limnaeus embryos 
 
Figure 6.10a. Deep blastomeres in a 5 dpf embryo (dispersed phase). 
Figure 6.10b. Aggregation of deep blastomeres in a 12 dpf embryo.  
 
Somites in medakafish are also known to stain positively for alkaline 
phosphatase activity (The Medaka Book 4.5.1. Alkaline phosphatase staining, 
http://www.shigen.nig.ac.jp/medaka/medakabook/).  A. limnaeus embryos at 
19 days post fertilization were stained for alkaline phosphatase activity as a 
positive control and appear deep purple in color (Figure 6.11).  The color is 
clearly a different hue from the earlier embryonic cells but could possibly be 
attributed to high concentrations alkaline phosphatase activity. 
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Figure 6.11. Alkaline phosphatase staining of somites in whole A. limnaeus 
embryos. 
 
Figure 6.11a. Somites stained in a 19 dpf embryo. 
Figure 6.11b. Close-up of somite staining in a 19 dpf embryo. 
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Significance of this study 
Work on human embryonic stem cell lines has been hindered by their 
notorious fragility.  Maintaining these cells in culture is both tedious and labor-
intensive (Institute, 2010).  Although recent studies have identified two novel 
compounds (Thiazovivin and Pyrintegrin) that acted to significantly increase 
cell survival by more than 30 fold, many obstacles still remain for using human 
stem cells in scientific research (Xu et al., 2010). 
With the current moratorium on federal funding of embryonic stem cell 
research in humans, additional cell sources such as fish models for embryonic 
stem cells may offer alternative avenues for the scientific study of these types 
of cells and may lead to the development of new protocols for their use.   The 
technical advantages to using fish ESCs in addition to the distinct and very 
unique characteristics of annual killifish development make Austrofundulus 
limnaeus an excellent model for vertebrate development.  The distinctive 
dispersion-reaggregation phase and their ability to enter diapause during 
embryonic development and subsequently survive a range of harsh 
environmental conditions make this species a unique candidate for a 
comparative in vitro system.    
Another advantage to establishing an embryonic stem cell line from a 
fish species is that fish are one of the most distantly related groups of 
vertebrates to the more widely used mammalian lines and therefore provide an 
excellent reference to vertebrate studies.  Finally, annual killifish embryos are 
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able to sustain a range of extreme environmental conditions such as 
anoxia/hypoxia and severe temperature fluctuations.  If pluri- or totipotent stem 
cells from Austrofundulus limnaeus retain the ability to survive such conditions 
this cell line has the potential to be a very powerful model for vertebrate 
research as well as for the delivery of stem cell therapy.  
Finally, the convenience of cell culture allows for controlled in vitro 
studies that can be compared to the in vivo models.  Cell culture also reduces 
the number of animals needed for each study and eliminates ethical concerns 
when experimental conditions are considered damaging.
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